<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
  <url>
    <loc>https://real-world-embedding.tistory.com</loc>
    <lastmod>2026-11-19T14:44:45+09:00</lastmod>
    <priority>1.0</priority>
  </url>
<url>
  <loc>https://real-world-embedding.tistory.com/category</loc>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/category/devOps</loc>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/category/devOps</loc>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/category/Pharmacology/News</loc>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/category/Pharmacology/News</loc>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/category/Pharmacology</loc>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/category/Pharmacology</loc>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/category/Pharmacology/BS</loc>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/category/Pharmacology/BS</loc>
</url>
<url><loc>https://real-world-embedding.tistory.com/tag</loc></url>
<url><loc>https://real-world-embedding.tistory.com/guestbook</loc></url>
<url><loc>https://real-world-embedding.tistory.com/m/guestbook</loc></url>
<url>
  <loc>https://real-world-embedding.tistory.com/notice/6</loc>
  <lastmod>2024-02-26T16:17:53+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/notice/6</loc>
  <lastmod>2024-02-26T16:17:53+09:00</lastmod>
</url>

<url>
  <loc>https://real-world-embedding.tistory.com/entry/Publication-of-AKS-452-Phase-II-Vaccine-Study-Results-in-Nature-Vaccines-Highlights-Advancements-of-Akston-Biosciences-Ambifect%C2%AE-Fc-fusion-Platform</loc>
  <lastmod>2024-02-28T10:20:25+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Publication-of-AKS-452-Phase-II-Vaccine-Study-Results-in-Nature-Vaccines-Highlights-Advancements-of-Akston-Biosciences-Ambifect%C2%AE-Fc-fusion-Platform</loc>
  <lastmod>2024-02-28T10:20:25+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Harvard-Gastroenterology-Specialist-Dr-Hamed-Khalili-Appointed-to-Vivante-Health-Clinical-Advisory-Board-for-Inflammatory-Bowel-Disease-Research</loc>
  <lastmod>2024-02-28T10:19:30+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Harvard-Gastroenterology-Specialist-Dr-Hamed-Khalili-Appointed-to-Vivante-Health-Clinical-Advisory-Board-for-Inflammatory-Bowel-Disease-Research</loc>
  <lastmod>2024-02-28T10:19:30+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Initiation-of-KOMET-008-Phase-1-Clinical-Trial-by-Kura-Oncology-with-Ziftomenib-and-Standard-Care-Combinations-for-Acute-Myeloid-Leukemia-Patients-with-Specific-Genetic-Alterations</loc>
  <lastmod>2024-02-28T10:18:41+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Initiation-of-KOMET-008-Phase-1-Clinical-Trial-by-Kura-Oncology-with-Ziftomenib-and-Standard-Care-Combinations-for-Acute-Myeloid-Leukemia-Patients-with-Specific-Genetic-Alterations</loc>
  <lastmod>2024-02-28T10:18:41+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/MoonLake-Immunotherapeutics-Receives-Unanimous-Support-for-Phase-3-Trial-of-Sonelokimab-in-Hidradenitis-Suppurativa-from-FDA-and-EMA</loc>
  <lastmod>2024-02-28T10:17:37+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/MoonLake-Immunotherapeutics-Receives-Unanimous-Support-for-Phase-3-Trial-of-Sonelokimab-in-Hidradenitis-Suppurativa-from-FDA-and-EMA</loc>
  <lastmod>2024-02-28T10:17:37+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/BioCity-Biopharma-Completes-Enrollment-for-IgA-Nephropathy-Cohort-in-Phase-II-Trial-of-SC0062-Aiming-to-Target-CKD-and-Proteinuria</loc>
  <lastmod>2024-02-28T10:16:18+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/BioCity-Biopharma-Completes-Enrollment-for-IgA-Nephropathy-Cohort-in-Phase-II-Trial-of-SC0062-Aiming-to-Target-CKD-and-Proteinuria</loc>
  <lastmod>2024-02-28T10:16:18+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Enhanced-Risk-Stratification-in-Stage-I-Melanoma-Patients-Achieved-Using-DecisionDx-Melanoma-Test-Over-Traditional-AJCC8-Methodology</loc>
  <lastmod>2024-02-28T10:15:31+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Enhanced-Risk-Stratification-in-Stage-I-Melanoma-Patients-Achieved-Using-DecisionDx-Melanoma-Test-Over-Traditional-AJCC8-Methodology</loc>
  <lastmod>2024-02-28T10:15:31+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Preliminary-Results-Display-Full-Tumor-Eradication-in-Non-surgical-Breast-Cancer-Patients-Using-IceCures-ProSense%C2%AE-Cryoablation-Therapy</loc>
  <lastmod>2024-02-28T10:14:26+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Preliminary-Results-Display-Full-Tumor-Eradication-in-Non-surgical-Breast-Cancer-Patients-Using-IceCures-ProSense%C2%AE-Cryoablation-Therapy</loc>
  <lastmod>2024-02-28T10:14:26+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/NewBiologix-Engages-with-Florabio-to-Transform-Gene-Therapy-Manufacturing-through-Advanced-HEK293-Cell-Line-Engineering</loc>
  <lastmod>2024-02-28T10:12:31+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/NewBiologix-Engages-with-Florabio-to-Transform-Gene-Therapy-Manufacturing-through-Advanced-HEK293-Cell-Line-Engineering</loc>
  <lastmod>2024-02-28T10:12:31+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Akili-and-Shionogi-Declare-Success-in-Phase-3-Clinical-Trial-for-EndeavorRx-as-ADHD-Treatment-for-Japanese-Children</loc>
  <lastmod>2024-02-28T10:11:10+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Akili-and-Shionogi-Declare-Success-in-Phase-3-Clinical-Trial-for-EndeavorRx-as-ADHD-Treatment-for-Japanese-Children</loc>
  <lastmod>2024-02-28T10:11:10+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Bitterroot-Bio-and-Biotheus-Forge-Partnership-for-Bispecific-Protein-Development-in-Cardiovascular-Immunotherapy</loc>
  <lastmod>2024-02-28T10:10:20+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Bitterroot-Bio-and-Biotheus-Forge-Partnership-for-Bispecific-Protein-Development-in-Cardiovascular-Immunotherapy</loc>
  <lastmod>2024-02-28T10:10:20+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/CG-Oncology-Initiates-PIVOT-006-Phase-3-Trial-for-Cretostimogene-Targeting-Intermediate-risk-Non-Muscle-Invasive-Bladder-Cancer</loc>
  <lastmod>2024-02-28T10:09:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/CG-Oncology-Initiates-PIVOT-006-Phase-3-Trial-for-Cretostimogene-Targeting-Intermediate-risk-Non-Muscle-Invasive-Bladder-Cancer</loc>
  <lastmod>2024-02-28T10:09:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Recce-Pharmaceuticals-Furthers-Ongoing-Phase-III-Clinical-Trial-of-RECCE%C2%AE-327-Targeting-Diabetic-Foot-Ulcer-Infections-with-Expanded-Patient-Recruitment</loc>
  <lastmod>2024-02-28T10:08:49+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Recce-Pharmaceuticals-Furthers-Ongoing-Phase-III-Clinical-Trial-of-RECCE%C2%AE-327-Targeting-Diabetic-Foot-Ulcer-Infections-with-Expanded-Patient-Recruitment</loc>
  <lastmod>2024-02-28T10:08:49+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Tonix-Pharmaceuticals-Reveals-Promising-Pharmacokinetics-of-Cyclobenzaprine-for-Fibromyalgia-in-Japan-and-China</loc>
  <lastmod>2024-02-28T10:07:52+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Tonix-Pharmaceuticals-Reveals-Promising-Pharmacokinetics-of-Cyclobenzaprine-for-Fibromyalgia-in-Japan-and-China</loc>
  <lastmod>2024-02-28T10:07:52+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Phylos-and-People-Science-Reveal-Clinical-Study-Outcomes-Demonstrating-the-Stimulating-Impact-of-Tetrahydrocannabivarin-THCV-on-Energy-Levels</loc>
  <lastmod>2024-02-28T10:06:45+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Phylos-and-People-Science-Reveal-Clinical-Study-Outcomes-Demonstrating-the-Stimulating-Impact-of-Tetrahydrocannabivarin-THCV-on-Energy-Levels</loc>
  <lastmod>2024-02-28T10:06:45+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Third-Pole-Therapeutics-Triumphs-with-eNOfit%E2%84%A2-System-EFS-for-Non-Hospital-Treatment-of-Pulmonary-Hypertension</loc>
  <lastmod>2024-02-28T10:05:56+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Third-Pole-Therapeutics-Triumphs-with-eNOfit%E2%84%A2-System-EFS-for-Non-Hospital-Treatment-of-Pulmonary-Hypertension</loc>
  <lastmod>2024-02-28T10:05:56+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Baseimmune-Secures-113-Million-Series-A-Investment-for-Accelerated-Development-of-AI-Designed-Cross-Protective-Vaccines</loc>
  <lastmod>2024-02-27T10:14:00+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Baseimmune-Secures-113-Million-Series-A-Investment-for-Accelerated-Development-of-AI-Designed-Cross-Protective-Vaccines</loc>
  <lastmod>2024-02-27T10:14:00+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/PolarityTE-Commences-Phase-III-Trial-for-SkinTE-in-Diabetic-Foot-Ulcers</loc>
  <lastmod>2024-02-27T10:13:06+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/PolarityTE-Commences-Phase-III-Trial-for-SkinTE-in-Diabetic-Foot-Ulcers</loc>
  <lastmod>2024-02-27T10:13:06+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Hoth-Therapeutics-Advances-Preclinical-Development-of-HT-KIT-With-Altasciences-Collaboration-for-Mast-Cell-Derived-Cancer-Treatment</loc>
  <lastmod>2024-02-27T10:11:16+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Hoth-Therapeutics-Advances-Preclinical-Development-of-HT-KIT-With-Altasciences-Collaboration-for-Mast-Cell-Derived-Cancer-Treatment</loc>
  <lastmod>2024-02-27T10:11:16+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Commencement-of-the-CONVERT-II-Pivotal-Trial-for-AeriSeal%C2%AE-System-A-Landmark-Study-by-Pulmonx-Corporation-Aiming-to-Treat-Severe-COPDEmphysema-Patients</loc>
  <lastmod>2024-02-27T10:06:50+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Commencement-of-the-CONVERT-II-Pivotal-Trial-for-AeriSeal%C2%AE-System-A-Landmark-Study-by-Pulmonx-Corporation-Aiming-to-Treat-Severe-COPDEmphysema-Patients</loc>
  <lastmod>2024-02-27T10:06:50+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Advancement-in-Acute-Myeloid-Leukemia-Treatment-Kura-Oncology-Initiates-Phase-1-KOMET-008-Trial-with-Ziftomenib-in-Combination-Therapies</loc>
  <lastmod>2024-02-27T10:05:34+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Advancement-in-Acute-Myeloid-Leukemia-Treatment-Kura-Oncology-Initiates-Phase-1-KOMET-008-Trial-with-Ziftomenib-in-Combination-Therapies</loc>
  <lastmod>2024-02-27T10:05:34+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/MoonLake-Immunotherapeutics-Receives-Endorsement-from-FDA-and-EMA-for-Phase-3-Program-of-Sonelokimab-in-Treating-Hidradenitis-Suppurativa</loc>
  <lastmod>2024-02-27T10:04:34+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/MoonLake-Immunotherapeutics-Receives-Endorsement-from-FDA-and-EMA-for-Phase-3-Program-of-Sonelokimab-in-Treating-Hidradenitis-Suppurativa</loc>
  <lastmod>2024-02-27T10:04:34+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/BioCity-Biopharma-Completes-Enrollment-for-IgA-Nephropathy-Patients-in-Phase-II-Trial-of-SC0062-Advancing-Chronic-Kidney-Disease-Treatment</loc>
  <lastmod>2024-02-27T09:36:15+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/BioCity-Biopharma-Completes-Enrollment-for-IgA-Nephropathy-Patients-in-Phase-II-Trial-of-SC0062-Advancing-Chronic-Kidney-Disease-Treatment</loc>
  <lastmod>2024-02-27T09:36:15+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/SSH-%EC%84%9C%EB%B2%84-%EB%B3%B4%EC%95%88-%EA%B0%95%ED%99%94%EB%A5%BC-%EC%9C%84%ED%95%9C-%EA%B8%B0%EB%B3%B8%EC%A0%81%EC%9D%B8-%EC%84%A4%EC%A0%95-%EB%B0%A9%EB%B2%95</loc>
  <lastmod>2023-07-31T10:49:14+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/SSH-%EC%84%9C%EB%B2%84-%EB%B3%B4%EC%95%88-%EA%B0%95%ED%99%94%EB%A5%BC-%EC%9C%84%ED%95%9C-%EA%B8%B0%EB%B3%B8%EC%A0%81%EC%9D%B8-%EC%84%A4%EC%A0%95-%EB%B0%A9%EB%B2%95</loc>
  <lastmod>2023-07-31T10:49:14+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/%ED%95%B4%ED%82%B9-%EB%B0%A9%EC%A7%80%EB%A5%BC-%EC%9C%84%ED%95%9C-Nginx-%EC%84%A4%EC%A0%95</loc>
  <lastmod>2023-07-31T10:31:48+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/%ED%95%B4%ED%82%B9-%EB%B0%A9%EC%A7%80%EB%A5%BC-%EC%9C%84%ED%95%9C-Nginx-%EC%84%A4%EC%A0%95</loc>
  <lastmod>2023-07-31T10:31:48+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/SSH-%EB%B3%B4%EC%95%88-%EA%B0%95%ED%99%94-fail2ban-%EC%9C%BC%EB%A1%9C-%EC%95%8C%EC%95%84%EB%B3%B4%EA%B8%B0</loc>
  <lastmod>2023-07-30T22:22:51+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/SSH-%EB%B3%B4%EC%95%88-%EA%B0%95%ED%99%94-fail2ban-%EC%9C%BC%EB%A1%9C-%EC%95%8C%EC%95%84%EB%B3%B4%EA%B8%B0</loc>
  <lastmod>2023-07-30T22:22:51+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/MindBio-Therapeutics-Begins-Recruitment-of-Participants-for-World-First-LSD-Microdosing-Clinical-Trial-in-Cancer-Patients-Experiencing-Emotional-Distress</loc>
  <lastmod>2023-07-26T13:36:17+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/MindBio-Therapeutics-Begins-Recruitment-of-Participants-for-World-First-LSD-Microdosing-Clinical-Trial-in-Cancer-Patients-Experiencing-Emotional-Distress</loc>
  <lastmod>2023-07-26T13:36:17+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Intrommune-Therapeutics-Completes-Last-Patient-Last-Visit-in-Phase-1-OMEGA-Study</loc>
  <lastmod>2023-07-26T17:29:28+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Intrommune-Therapeutics-Completes-Last-Patient-Last-Visit-in-Phase-1-OMEGA-Study</loc>
  <lastmod>2023-07-26T17:29:28+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Thermo-Fisher-Relies-on-CYBRA%E2%80%99s-RFID-Tracking-and-Alerting-Capabilities-to-Keep-Blood-Cold</loc>
  <lastmod>2023-07-26T13:33:25+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Thermo-Fisher-Relies-on-CYBRA%E2%80%99s-RFID-Tracking-and-Alerting-Capabilities-to-Keep-Blood-Cold</loc>
  <lastmod>2023-07-26T13:33:25+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Rosalind-Franklin-University-Researcher-Awarded-NIH-Funding-to-Investigate-Links-Between-Down-Syndrome-and-Alzheimers-Disease</loc>
  <lastmod>2023-07-26T13:32:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Rosalind-Franklin-University-Researcher-Awarded-NIH-Funding-to-Investigate-Links-Between-Down-Syndrome-and-Alzheimers-Disease</loc>
  <lastmod>2023-07-26T13:32:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Illumina-and-Pillar-Biosciences-partner-to-improve-access-to-personalized-cancer-treatment-options</loc>
  <lastmod>2023-07-31T22:14:14+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Illumina-and-Pillar-Biosciences-partner-to-improve-access-to-personalized-cancer-treatment-options</loc>
  <lastmod>2023-07-31T22:14:14+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/VitaGraft-Kidneys-Ability-to-Differentiate-ABMR-and-IgAN-in-Kidney-Transplant-Patients</loc>
  <lastmod>2023-07-26T13:31:11+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/VitaGraft-Kidneys-Ability-to-Differentiate-ABMR-and-IgAN-in-Kidney-Transplant-Patients</loc>
  <lastmod>2023-07-26T13:31:11+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/IntelGenx-Provides-Update-on-Research-Collaboration-Evaluating-Montelukast-VersaFilm%C2%AE-for-the-Treatment-of-Parkinson%E2%80%99s-Disease</loc>
  <lastmod>2023-07-26T13:30:27+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/IntelGenx-Provides-Update-on-Research-Collaboration-Evaluating-Montelukast-VersaFilm%C2%AE-for-the-Treatment-of-Parkinson%E2%80%99s-Disease</loc>
  <lastmod>2023-07-26T13:30:27+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Crescendo-Biologics-secures-32M-and-announces-expansion-of-CB307-Phase-1b-trial-in-PSMA-solid-tumours</loc>
  <lastmod>2023-07-24T22:29:18+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Crescendo-Biologics-secures-32M-and-announces-expansion-of-CB307-Phase-1b-trial-in-PSMA-solid-tumours</loc>
  <lastmod>2023-07-24T22:29:18+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Orthogon-Therapeutics-Celebrates-Major-Technical-Milestone-and-Secures-Additional-6M-Toward-a-Pioneering-Drug-for-BK-Virus</loc>
  <lastmod>2023-07-24T22:28:29+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Orthogon-Therapeutics-Celebrates-Major-Technical-Milestone-and-Secures-Additional-6M-Toward-a-Pioneering-Drug-for-BK-Virus</loc>
  <lastmod>2023-07-24T22:28:29+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Quince-Therapeutics-to-Acquire-EryDel-SpA-and-its-Phase-3-Asset-Targeting-Ataxia-Telangiectasia-with-No-Currently-Approved-Treatments-and-Estimated-1-Billion-Peak-Sales-Opportunity</loc>
  <lastmod>2023-07-24T22:27:38+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Quince-Therapeutics-to-Acquire-EryDel-SpA-and-its-Phase-3-Asset-Targeting-Ataxia-Telangiectasia-with-No-Currently-Approved-Treatments-and-Estimated-1-Billion-Peak-Sales-Opportunity</loc>
  <lastmod>2023-07-24T22:27:38+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/DiaCarta-Partners-with-HMCHML-for-Lab-Development-Test-Validations-and-Compliances-in-the-US-Market</loc>
  <lastmod>2023-07-24T22:26:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/DiaCarta-Partners-with-HMCHML-for-Lab-Development-Test-Validations-and-Compliances-in-the-US-Market</loc>
  <lastmod>2023-07-24T22:26:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Lineage-Cell-Therapeutics-and-Cancer-Research-UK-Report-Topline-Phase-1-Study-Results-With-VAC2-for-the-Treatment-of-Advanced-Non-small-Cell-Lung-Cancer</loc>
  <lastmod>2023-07-24T22:25:54+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Lineage-Cell-Therapeutics-and-Cancer-Research-UK-Report-Topline-Phase-1-Study-Results-With-VAC2-for-the-Treatment-of-Advanced-Non-small-Cell-Lung-Cancer</loc>
  <lastmod>2023-07-24T22:25:54+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/CG-Oncology-Completes-Patient-Enrollment-in-BOND-003-Phase-3-Monotherapy-Study-with-Cretostimogene-Grenadenorepvec-in-BCG-Unresponsive-High-Risk-NMIBC</loc>
  <lastmod>2023-07-24T22:24:57+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/CG-Oncology-Completes-Patient-Enrollment-in-BOND-003-Phase-3-Monotherapy-Study-with-Cretostimogene-Grenadenorepvec-in-BCG-Unresponsive-High-Risk-NMIBC</loc>
  <lastmod>2023-07-24T22:24:57+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Enveric-Biosciences-Reports-Positive-Results-from-Preclinical-Studies-Supporting-Metabolic-Profile-of-Lead-Candidate-EB-373</loc>
  <lastmod>2023-07-24T22:24:06+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Enveric-Biosciences-Reports-Positive-Results-from-Preclinical-Studies-Supporting-Metabolic-Profile-of-Lead-Candidate-EB-373</loc>
  <lastmod>2023-07-24T22:24:06+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Nectero-Medical-Receives-FDA-Clearance-of-IND-Application-to-Initiate-Phase-IIIII-Clinical-Trial-of-Nectero-EAST%C2%AE-System-for-Treatment-of-Small-to-Mid-Sized-Abdominal-Aortic-Aneurysms</loc>
  <lastmod>2023-07-24T22:21:59+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Nectero-Medical-Receives-FDA-Clearance-of-IND-Application-to-Initiate-Phase-IIIII-Clinical-Trial-of-Nectero-EAST%C2%AE-System-for-Treatment-of-Small-to-Mid-Sized-Abdominal-Aortic-Aneurysms</loc>
  <lastmod>2023-07-24T22:21:59+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Myriad-Genetics-Announces-Inclusion-of-Breast-Density-to-MyRisk%C2%AE-with-RiskScore%C2%AE-Breast-Cancer-Risk-Assessment</loc>
  <lastmod>2023-07-24T22:21:07+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Myriad-Genetics-Announces-Inclusion-of-Breast-Density-to-MyRisk%C2%AE-with-RiskScore%C2%AE-Breast-Cancer-Risk-Assessment</loc>
  <lastmod>2023-07-24T22:21:07+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/PaxMedica-Announces-Positive-Top-Line-Results-from-the-PAX-101-intravenous-suramin-Phase-3-African-Sleeping-Sickness-Study</loc>
  <lastmod>2023-07-24T22:20:15+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/PaxMedica-Announces-Positive-Top-Line-Results-from-the-PAX-101-intravenous-suramin-Phase-3-African-Sleeping-Sickness-Study</loc>
  <lastmod>2023-07-24T22:20:15+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Syndax-and-Incyte-Announce-Positive-Topline-Results-from-the-Pivotal-AGAVE-201-Trial-of-Axatilimab-in-Chronic-Graft-Versus-Host-Disease</loc>
  <lastmod>2023-07-24T22:19:23+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Syndax-and-Incyte-Announce-Positive-Topline-Results-from-the-Pivotal-AGAVE-201-Trial-of-Axatilimab-in-Chronic-Graft-Versus-Host-Disease</loc>
  <lastmod>2023-07-24T22:19:23+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/BioCardia-Announces-Pause-in-Enrollment-for-Phase-III-Pivotal-CardiAMP-Cell-Therapy-Heart-Failure-Trial</loc>
  <lastmod>2023-07-24T22:18:27+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/BioCardia-Announces-Pause-in-Enrollment-for-Phase-III-Pivotal-CardiAMP-Cell-Therapy-Heart-Failure-Trial</loc>
  <lastmod>2023-07-24T22:18:27+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Immatics-Announces-35-Million-Equity-Investment-from-Bristol-Myers-Squibb</loc>
  <lastmod>2023-07-24T22:16:10+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Immatics-Announces-35-Million-Equity-Investment-from-Bristol-Myers-Squibb</loc>
  <lastmod>2023-07-24T22:16:10+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Grifols-Achieves-Positive-Topline-Results-From-Phase-4-Study-of-XEMBIFY%C2%AE-immune</loc>
  <lastmod>2023-07-23T12:14:20+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Grifols-Achieves-Positive-Topline-Results-From-Phase-4-Study-of-XEMBIFY%C2%AE-immune</loc>
  <lastmod>2023-07-23T12:14:20+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/GeneCentric-Therapeutics-Announces-Publication-of-New-Results-Showing-Clinical-Benefit-of-RNA-based-Antifolate-Predictive-Response-Signature-AF-PRS-to-Guide-Lung-Cancer-Treatment-Selection</loc>
  <lastmod>2023-07-21T07:13:14+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/GeneCentric-Therapeutics-Announces-Publication-of-New-Results-Showing-Clinical-Benefit-of-RNA-based-Antifolate-Predictive-Response-Signature-AF-PRS-to-Guide-Lung-Cancer-Treatment-Selection</loc>
  <lastmod>2023-07-21T07:13:14+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Soaak-Technologies-Awarded-Phase-I-Small-Business-Innovation-Research-SBIR-Contract-from-the-US-Air-Force</loc>
  <lastmod>2023-07-21T07:12:28+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Soaak-Technologies-Awarded-Phase-I-Small-Business-Innovation-Research-SBIR-Contract-from-the-US-Air-Force</loc>
  <lastmod>2023-07-21T07:12:28+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Rarecells-Inc-Announces-Breakthrough-Publication-on-Circulating-Giant-Cancer-Cells-Detected-in-Patients-with-MDS</loc>
  <lastmod>2023-07-21T07:11:40+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Rarecells-Inc-Announces-Breakthrough-Publication-on-Circulating-Giant-Cancer-Cells-Detected-in-Patients-with-MDS</loc>
  <lastmod>2023-07-21T07:11:40+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Palvella-Therapeutics-Reports-Topline-Results-from-Pivotal-Phase-3-VAPAUS-Study-of-QTORIN%E2%84%A2-39-Rapamycin-Anhydrous-Gel-QTORIN%E2%84%A2-rapamycin-for-the-Treatment-of-Pachyonychia-Congenita</loc>
  <lastmod>2023-07-21T07:10:52+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Palvella-Therapeutics-Reports-Topline-Results-from-Pivotal-Phase-3-VAPAUS-Study-of-QTORIN%E2%84%A2-39-Rapamycin-Anhydrous-Gel-QTORIN%E2%84%A2-rapamycin-for-the-Treatment-of-Pachyonychia-Congenita</loc>
  <lastmod>2023-07-21T07:10:52+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Sight-Sciences-Announces-Positive-Results-and-Primary-Endpoint-Successfully-Met-in-SAHARA</loc>
  <lastmod>2023-07-22T10:47:27+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Sight-Sciences-Announces-Positive-Results-and-Primary-Endpoint-Successfully-Met-in-SAHARA</loc>
  <lastmod>2023-07-22T10:47:27+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Suono-Bio-Reports-Encouraging-Results-From-First-in-Human-Study-of-Ultrasound-Mediated-Drug-Delivery-Platform</loc>
  <lastmod>2023-07-21T07:09:22+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Suono-Bio-Reports-Encouraging-Results-From-First-in-Human-Study-of-Ultrasound-Mediated-Drug-Delivery-Platform</loc>
  <lastmod>2023-07-21T07:09:22+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/RenovoRx-and-Imugene-Announce-Collaboration-to-Deliver-Oncolytic-Virus-Therapy-Using-Proprietary-Trans-Arterial-Micro-Perfusion-TAMP%E2%84%A2-Platform</loc>
  <lastmod>2023-07-21T07:08:38+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/RenovoRx-and-Imugene-Announce-Collaboration-to-Deliver-Oncolytic-Virus-Therapy-Using-Proprietary-Trans-Arterial-Micro-Perfusion-TAMP%E2%84%A2-Platform</loc>
  <lastmod>2023-07-21T07:08:38+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Palvella-Therapeutics-Announces-Planned-Pivotal-Phase-3-Study-Design-of-QTORIN%E2%84%A2-39-Rapamycin-Anhydrous-Gel-for-the-Treatment-of-Microcystic-Lymphatic-Malformations</loc>
  <lastmod>2023-07-21T07:07:49+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Palvella-Therapeutics-Announces-Planned-Pivotal-Phase-3-Study-Design-of-QTORIN%E2%84%A2-39-Rapamycin-Anhydrous-Gel-for-the-Treatment-of-Microcystic-Lymphatic-Malformations</loc>
  <lastmod>2023-07-21T07:07:49+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Harmony-Biosciences-Announces-Plans-to-Initiate-Phase-3-Registrational-Study-of-Pitolisant-in-Prader-Willi-Syndrome</loc>
  <lastmod>2023-07-21T07:07:03+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Harmony-Biosciences-Announces-Plans-to-Initiate-Phase-3-Registrational-Study-of-Pitolisant-in-Prader-Willi-Syndrome</loc>
  <lastmod>2023-07-21T07:07:03+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Perfuse-Therapeutics-Announces-Initiation-of-Enrollment-to-Ph2a-Portion-of-the-Phase-12a-Clinical-Trial-of-PER-001-Intravitreal-Implant-in-Patients-with-Glaucoma</loc>
  <lastmod>2023-07-21T07:06:12+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Perfuse-Therapeutics-Announces-Initiation-of-Enrollment-to-Ph2a-Portion-of-the-Phase-12a-Clinical-Trial-of-PER-001-Intravitreal-Implant-in-Patients-with-Glaucoma</loc>
  <lastmod>2023-07-21T07:06:12+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Promontory-Therapeutics-Expands-Phase-2-Trial-of-PT-112-in-Metastatic-Castrate-Resistant-Prostate-Cancer-to-France</loc>
  <lastmod>2023-07-21T07:05:23+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Promontory-Therapeutics-Expands-Phase-2-Trial-of-PT-112-in-Metastatic-Castrate-Resistant-Prostate-Cancer-to-France</loc>
  <lastmod>2023-07-21T07:05:23+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Phase-2-PENINSULA-Trial-Evaluating-VIR-2482-for-the-Prevention-of-Seasonal-Influenza-A-Illness-Does-Not-Meet-Efficacy-Endpoints</loc>
  <lastmod>2023-07-21T07:04:34+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Phase-2-PENINSULA-Trial-Evaluating-VIR-2482-for-the-Prevention-of-Seasonal-Influenza-A-Illness-Does-Not-Meet-Efficacy-Endpoints</loc>
  <lastmod>2023-07-21T07:04:34+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Recludix-Pharma-Enters-into-a-Strategic-Collaboration-with-Sanofi-to-Advance-Novel-Oral-STAT6-Inhibitor-in-Multiple-Immunological-and-Inflammatory-Indications</loc>
  <lastmod>2023-07-21T07:03:48+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Recludix-Pharma-Enters-into-a-Strategic-Collaboration-with-Sanofi-to-Advance-Novel-Oral-STAT6-Inhibitor-in-Multiple-Immunological-and-Inflammatory-Indications</loc>
  <lastmod>2023-07-21T07:03:48+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/23andMe-Releases-New-FDA-Cleared-Genetic-Report-on-Simvastatin</loc>
  <lastmod>2023-07-21T07:03:06+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/23andMe-Releases-New-FDA-Cleared-Genetic-Report-on-Simvastatin</loc>
  <lastmod>2023-07-21T07:03:06+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Biomica-Announces-Interim-Positive-Results-from-Pre-Clinical-Studies-in-its-Irritable-Bowel-Syndrome-IBS-Program</loc>
  <lastmod>2023-07-19T23:04:25+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Biomica-Announces-Interim-Positive-Results-from-Pre-Clinical-Studies-in-its-Irritable-Bowel-Syndrome-IBS-Program</loc>
  <lastmod>2023-07-19T23:04:25+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/GeneDx-and-Prognos-Health-Announce-Strategic-Partnership-to-Help-Rare-Disease-Patients-More-Rapidly-Gain-Access-to-Potential-Treatment-Options</loc>
  <lastmod>2023-07-19T23:03:30+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/GeneDx-and-Prognos-Health-Announce-Strategic-Partnership-to-Help-Rare-Disease-Patients-More-Rapidly-Gain-Access-to-Potential-Treatment-Options</loc>
  <lastmod>2023-07-19T23:03:30+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/BioCryst-Partners-with-Er-Kim-Pharmaceuticals-for-Commercialization-of-ORLADEYO%C2%AE</loc>
  <lastmod>2023-07-23T12:13:36+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/BioCryst-Partners-with-Er-Kim-Pharmaceuticals-for-Commercialization-of-ORLADEYO%C2%AE</loc>
  <lastmod>2023-07-23T12:13:36+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Teleflex-Completes-Enrollment-in-RingerTM-PTCA-Study</loc>
  <lastmod>2023-07-19T23:01:42+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Teleflex-Completes-Enrollment-in-RingerTM-PTCA-Study</loc>
  <lastmod>2023-07-19T23:01:42+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/MindBio-Therapeutics-Begins-Pre-Screening-Participants-for-World-First-Phase-2-Take-Home-LSD-Microdosing-Clinical-Trial-in-Patients-with-Major-Depressive-Disorder</loc>
  <lastmod>2023-07-19T23:00:49+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/MindBio-Therapeutics-Begins-Pre-Screening-Participants-for-World-First-Phase-2-Take-Home-LSD-Microdosing-Clinical-Trial-in-Patients-with-Major-Depressive-Disorder</loc>
  <lastmod>2023-07-19T23:00:49+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/SURGE-Therapeutics-Raises-32M-Series-B-Financing-to-Advance-Intraoperative-Immunotherapy-to-Improve-Cancer-Patient-Survival-Outcomes-Post-Surgery</loc>
  <lastmod>2023-07-19T22:59:56+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/SURGE-Therapeutics-Raises-32M-Series-B-Financing-to-Advance-Intraoperative-Immunotherapy-to-Improve-Cancer-Patient-Survival-Outcomes-Post-Surgery</loc>
  <lastmod>2023-07-19T22:59:56+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/VBI-Vaccines-Announces-PreHevbri%C2%AE-is-Now-Available-in-the-Netherlands-and-Belgium-for-the-Prevention-of-Hepatitis-B-in-Adults</loc>
  <lastmod>2023-07-19T22:59:02+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/VBI-Vaccines-Announces-PreHevbri%C2%AE-is-Now-Available-in-the-Netherlands-and-Belgium-for-the-Prevention-of-Hepatitis-B-in-Adults</loc>
  <lastmod>2023-07-19T22:59:02+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Hoth-Therapeutics-Receives-Protocol-Approval-for-HT-001-Cancer-Therapeutic</loc>
  <lastmod>2023-07-19T22:58:10+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Hoth-Therapeutics-Receives-Protocol-Approval-for-HT-001-Cancer-Therapeutic</loc>
  <lastmod>2023-07-19T22:58:10+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Reveal-Lasers-LLC-Announces-Acquisition-of-AgeJET-Advanced-Plasma-Skin-Therapy-Device</loc>
  <lastmod>2023-07-19T22:57:14+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Reveal-Lasers-LLC-Announces-Acquisition-of-AgeJET-Advanced-Plasma-Skin-Therapy-Device</loc>
  <lastmod>2023-07-19T22:57:14+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Inspira-Technologies-Enters-into-Collaboration-Agreement-with-US-Based-Perfusion-Solution-Inc</loc>
  <lastmod>2023-07-19T22:56:22+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Inspira-Technologies-Enters-into-Collaboration-Agreement-with-US-Based-Perfusion-Solution-Inc</loc>
  <lastmod>2023-07-19T22:56:22+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Kintara-Therapeutics-to-Participate-in-the-Fifth-Annual-Glioblastoma-Awareness-Day-in-Washington-DC</loc>
  <lastmod>2023-07-19T22:55:30+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Kintara-Therapeutics-to-Participate-in-the-Fifth-Annual-Glioblastoma-Awareness-Day-in-Washington-DC</loc>
  <lastmod>2023-07-19T22:55:30+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Synaptogenix-and-Cleveland-Clinic-to-Submit-Investigational-New-Drug-IND-Application-to-FDA-for-Clinical-Trial-of-Bryostatin-1-in-Multiple-Sclerosis</loc>
  <lastmod>2023-07-19T22:54:39+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Synaptogenix-and-Cleveland-Clinic-to-Submit-Investigational-New-Drug-IND-Application-to-FDA-for-Clinical-Trial-of-Bryostatin-1-in-Multiple-Sclerosis</loc>
  <lastmod>2023-07-19T22:54:39+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Abeona-Therapeutics-Joins-Rare-Disease-Company-Coalition</loc>
  <lastmod>2023-07-19T22:53:53+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Abeona-Therapeutics-Joins-Rare-Disease-Company-Coalition</loc>
  <lastmod>2023-07-19T22:53:53+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Emergex-Reports-Promising-Data-from-Completed-Swiss-Phase-I-Trial-of-CoronaTcP%E2%84%A2-T-Cell-Priming-Immune-Set-Point-Candidate-for-Betacoronaviruses</loc>
  <lastmod>2023-07-19T22:53:04+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Emergex-Reports-Promising-Data-from-Completed-Swiss-Phase-I-Trial-of-CoronaTcP%E2%84%A2-T-Cell-Priming-Immune-Set-Point-Candidate-for-Betacoronaviruses</loc>
  <lastmod>2023-07-19T22:53:04+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/LiVeritas-Biosciences-Introduces-the-LiLii%E2%84%A2-Platform-An-Integrated-Laboratory-Ecosystem-Powered-by-AI</loc>
  <lastmod>2023-07-19T22:52:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/LiVeritas-Biosciences-Introduces-the-LiLii%E2%84%A2-Platform-An-Integrated-Laboratory-Ecosystem-Powered-by-AI</loc>
  <lastmod>2023-07-19T22:52:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Caeregen-Therapeutics-Receives-14-Million-Phase-2-SBIR-Grant-from-NIHNEI-to-Advance-Development-of-Regenerative-Medicine-Clinical-Candidate-CTR-107-Noregen%E2%84%A2-for-Retinal-Diseases</loc>
  <lastmod>2023-07-18T10:44:12+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Caeregen-Therapeutics-Receives-14-Million-Phase-2-SBIR-Grant-from-NIHNEI-to-Advance-Development-of-Regenerative-Medicine-Clinical-Candidate-CTR-107-Noregen%E2%84%A2-for-Retinal-Diseases</loc>
  <lastmod>2023-07-18T10:44:12+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Cumulus-Neuroscience-Presents-Data-on-Feasibility-of-Functional-Neurophysiology-in-Alzheimers-Disease-Dementia-at-AAIC-2023-Annual-Meeting</loc>
  <lastmod>2023-07-18T10:43:23+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Cumulus-Neuroscience-Presents-Data-on-Feasibility-of-Functional-Neurophysiology-in-Alzheimers-Disease-Dementia-at-AAIC-2023-Annual-Meeting</loc>
  <lastmod>2023-07-18T10:43:23+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Adcentrx-Therapeutics-Announces-FDA-Clearance-of-Investigational-New-Drug-Application-for-ADRX-0706-a-Novel-ADC-Targeting-Nectin-4-for-the-Treatment-of-Advanced-Solid-Tumors</loc>
  <lastmod>2023-07-19T06:46:03+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Adcentrx-Therapeutics-Announces-FDA-Clearance-of-Investigational-New-Drug-Application-for-ADRX-0706-a-Novel-ADC-Targeting-Nectin-4-for-the-Treatment-of-Advanced-Solid-Tumors</loc>
  <lastmod>2023-07-19T06:46:03+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Elevar-Therapeutics-Announces-FDA-Acceptance-for-Filing-of-New-Drug-Application-for-Rivoceranib-in-Combination-with-Camrelizumab-as-a-First-line-Treatment-for-Unresectable-Hepatocellular-Carcinoma</loc>
  <lastmod>2023-07-19T06:46:22+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Elevar-Therapeutics-Announces-FDA-Acceptance-for-Filing-of-New-Drug-Application-for-Rivoceranib-in-Combination-with-Camrelizumab-as-a-First-line-Treatment-for-Unresectable-Hepatocellular-Carcinoma</loc>
  <lastmod>2023-07-19T06:46:22+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/EMA-Accepts-MAA-for-DMB-3115-a-Stelara-Biosimilar-by-Dong-A-ST</loc>
  <lastmod>2023-07-18T10:40:50+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/EMA-Accepts-MAA-for-DMB-3115-a-Stelara-Biosimilar-by-Dong-A-ST</loc>
  <lastmod>2023-07-18T10:40:50+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/ALZHEIMERS-ASSOCIATION-STATEMENT-ON-DONANEMAB-PHASE-3-DATA-REPORTED-AT-AAIC-2023</loc>
  <lastmod>2023-07-19T06:46:40+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/ALZHEIMERS-ASSOCIATION-STATEMENT-ON-DONANEMAB-PHASE-3-DATA-REPORTED-AT-AAIC-2023</loc>
  <lastmod>2023-07-19T06:46:40+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Clearside-Biomedical-Announces-Enrollment-of-Multiple-Participants-in-its-ODYSSEY-Phase-2b-Clinical-Trial-of-CLS-AX-axitinib-injectable-suspension-in-Wet-AMD</loc>
  <lastmod>2023-07-18T10:39:14+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Clearside-Biomedical-Announces-Enrollment-of-Multiple-Participants-in-its-ODYSSEY-Phase-2b-Clinical-Trial-of-CLS-AX-axitinib-injectable-suspension-in-Wet-AMD</loc>
  <lastmod>2023-07-18T10:39:14+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Acumen-Pharmaceuticals-to-Hold-Conference-Call-to-Discuss-Positive-Topline-Results-from-First-in-Human-Phase-1-Study-of-ACU193-for-Early-Alzheimer%E2%80%99s-Disease</loc>
  <lastmod>2023-07-18T10:37:04+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Acumen-Pharmaceuticals-to-Hold-Conference-Call-to-Discuss-Positive-Topline-Results-from-First-in-Human-Phase-1-Study-of-ACU193-for-Early-Alzheimer%E2%80%99s-Disease</loc>
  <lastmod>2023-07-18T10:37:04+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Positive-Data-Shows-Improvement-in-Multiple-Long-COVID-Symptoms-with-Valacyclovir-and-Celecoxib-Treatment</loc>
  <lastmod>2023-07-18T10:36:21+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Positive-Data-Shows-Improvement-in-Multiple-Long-COVID-Symptoms-with-Valacyclovir-and-Celecoxib-Treatment</loc>
  <lastmod>2023-07-18T10:36:21+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Searx-%EA%B0%9C%EC%9D%B8-%EC%A0%95%EB%B3%B4-%EB%B3%B4%ED%98%B8%EC%99%80-%EA%B2%80%EC%83%89-%EC%9E%90%EC%9C%A0%EB%A5%BC-%EC%9C%84%ED%95%9C-%EC%98%A4%ED%94%88-%EC%86%8C%EC%8A%A4-%EB%A9%94%ED%83%80-%EA%B2%80%EC%83%89-%EC%97%94%EC%A7%84</loc>
  <lastmod>2023-07-17T12:48:12+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Searx-%EA%B0%9C%EC%9D%B8-%EC%A0%95%EB%B3%B4-%EB%B3%B4%ED%98%B8%EC%99%80-%EA%B2%80%EC%83%89-%EC%9E%90%EC%9C%A0%EB%A5%BC-%EC%9C%84%ED%95%9C-%EC%98%A4%ED%94%88-%EC%86%8C%EC%8A%A4-%EB%A9%94%ED%83%80-%EA%B2%80%EC%83%89-%EC%97%94%EC%A7%84</loc>
  <lastmod>2023-07-17T12:48:12+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Neural-Therapeutics-Inc-Closes-Rights-Offering</loc>
  <lastmod>2023-07-16T14:34:32+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Neural-Therapeutics-Inc-Closes-Rights-Offering</loc>
  <lastmod>2023-07-16T14:34:32+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/CEL-SCI-Concludes-Positive-Meeting-With-US-FDA-Concerning-Multikine%E2%80%99s-Approval-for-Head-Neck-Cancer</loc>
  <lastmod>2023-07-16T14:34:46+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/CEL-SCI-Concludes-Positive-Meeting-With-US-FDA-Concerning-Multikine%E2%80%99s-Approval-for-Head-Neck-Cancer</loc>
  <lastmod>2023-07-16T14:34:46+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/ReCor-Responds-to-European-Society-of-Hypertension%E2%80%99s-ESH-Updated-Guidelines-for-Management-of-Arterial-Hypertension</loc>
  <lastmod>2023-07-16T14:35:08+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/ReCor-Responds-to-European-Society-of-Hypertension%E2%80%99s-ESH-Updated-Guidelines-for-Management-of-Arterial-Hypertension</loc>
  <lastmod>2023-07-16T14:35:08+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Leading-United-States-Based-Hospital-Initiates-Senhance-Surgical-System-Program-for-Pediatric-Surgery</loc>
  <lastmod>2023-07-16T14:21:29+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Leading-United-States-Based-Hospital-Initiates-Senhance-Surgical-System-Program-for-Pediatric-Surgery</loc>
  <lastmod>2023-07-16T14:21:29+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Alphyn-Biologics-Reports-Encouraging-Interim-Results-of-Phase-2a-Trial-for-Atopic-Dermatitis-with-Secondary-Bacterial-Infection</loc>
  <lastmod>2023-07-16T14:35:26+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Alphyn-Biologics-Reports-Encouraging-Interim-Results-of-Phase-2a-Trial-for-Atopic-Dermatitis-with-Secondary-Bacterial-Infection</loc>
  <lastmod>2023-07-16T14:35:26+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/ProMIS-Completes-Continuance-to-Ontario</loc>
  <lastmod>2023-07-16T14:20:03+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/ProMIS-Completes-Continuance-to-Ontario</loc>
  <lastmod>2023-07-16T14:20:03+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/CurvaFix-Closes-39-Million-Series-C-Financing-Round-Led-by-MVM-Partners-and-Announces-CEO-Transition</loc>
  <lastmod>2023-07-16T14:19:26+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/CurvaFix-Closes-39-Million-Series-C-Financing-Round-Led-by-MVM-Partners-and-Announces-CEO-Transition</loc>
  <lastmod>2023-07-16T14:19:26+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Jenkins%EB%A1%9C-CICD-%EA%B5%AC%EC%B6%95%ED%95%98%EA%B8%B0-%EC%9A%B0%EB%B6%84%ED%88%AC-%ED%99%98%EA%B2%BD%EC%97%90%EC%84%9C-%EC%9E%90%EB%8F%99%ED%99%94%EB%90%9C-%EB%B9%8C%EB%93%9C-%EB%B0%8F-%EB%B0%B0%ED%8F%AC</loc>
  <lastmod>2023-07-16T02:00:52+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Jenkins%EB%A1%9C-CICD-%EA%B5%AC%EC%B6%95%ED%95%98%EA%B8%B0-%EC%9A%B0%EB%B6%84%ED%88%AC-%ED%99%98%EA%B2%BD%EC%97%90%EC%84%9C-%EC%9E%90%EB%8F%99%ED%99%94%EB%90%9C-%EB%B9%8C%EB%93%9C-%EB%B0%8F-%EB%B0%B0%ED%8F%AC</loc>
  <lastmod>2023-07-16T02:00:52+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Mercury-Bio-and-Himed-Partner-to-Develop-Novel-Osteogenic-Material-for-Orthopedic-Applications</loc>
  <lastmod>2023-07-14T16:34:02+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Mercury-Bio-and-Himed-Partner-to-Develop-Novel-Osteogenic-Material-for-Orthopedic-Applications</loc>
  <lastmod>2023-07-14T16:34:02+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Grifols-Meets-Enrollment-Target-in-Phase-3-Study-of-Two-Dose-Regimens-of-Prolastin%C2%AE-C-in-Patients-with-Emphysema-Due-to-Alpha-1-Antitrypsin-Deficiency</loc>
  <lastmod>2023-07-17T08:55:06+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Grifols-Meets-Enrollment-Target-in-Phase-3-Study-of-Two-Dose-Regimens-of-Prolastin%C2%AE-C-in-Patients-with-Emphysema-Due-to-Alpha-1-Antitrypsin-Deficiency</loc>
  <lastmod>2023-07-17T08:55:06+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Incannex-Receives-HREC-Approval-for-Phase-2-Clinical-Trial-Assessing-IHL-675A-for-use-in-Treatment-of-Pain-and-Function-in-Rheumatoid-Arthritis</loc>
  <lastmod>2023-07-14T16:32:27+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Incannex-Receives-HREC-Approval-for-Phase-2-Clinical-Trial-Assessing-IHL-675A-for-use-in-Treatment-of-Pain-and-Function-in-Rheumatoid-Arthritis</loc>
  <lastmod>2023-07-14T16:32:27+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Health-Canada-Approves-Lynparza-in-Combination-with-Abiraterone-and-Prednisone-or-Prednisolone-for-Patients-with-BRCA-Mutated-Metastatic-Castration-Resistant-Prostate-Cancer</loc>
  <lastmod>2023-07-14T17:38:53+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Health-Canada-Approves-Lynparza-in-Combination-with-Abiraterone-and-Prednisone-or-Prednisolone-for-Patients-with-BRCA-Mutated-Metastatic-Castration-Resistant-Prostate-Cancer</loc>
  <lastmod>2023-07-14T17:38:53+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/electroCore-Inc-Announces-Distribution-Agreement-with-Reliefband-Technologies-LLC</loc>
  <lastmod>2023-07-14T17:39:17+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/electroCore-Inc-Announces-Distribution-Agreement-with-Reliefband-Technologies-LLC</loc>
  <lastmod>2023-07-14T17:39:17+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Inogen-Expands-Its-Respiratory-Product-Portfolio-with-Acquisition-of-Physio-Assist</loc>
  <lastmod>2023-07-14T16:29:56+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Inogen-Expands-Its-Respiratory-Product-Portfolio-with-Acquisition-of-Physio-Assist</loc>
  <lastmod>2023-07-14T16:29:56+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Simulations-Plus-Releases-ADMET-Predictor%C2%AE-11</loc>
  <lastmod>2023-07-14T19:56:30+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Simulations-Plus-Releases-ADMET-Predictor%C2%AE-11</loc>
  <lastmod>2023-07-14T19:56:30+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Quest-Diagnostics-Launches-Novel-Prostate-Cancer-Test-Aimed-at-Improving-Diagnosis-and-Grading</loc>
  <lastmod>2023-07-14T16:27:01+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Quest-Diagnostics-Launches-Novel-Prostate-Cancer-Test-Aimed-at-Improving-Diagnosis-and-Grading</loc>
  <lastmod>2023-07-14T16:27:01+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Moleculin-Announces-Publication-of-Data-from-Successful-European-Phase-1-Trial-Evaluating-Annamycin-as-Single-Agent-Treatment-of-Relapsed-or-Refractory-Acute-Myeloid-Leukemia-AML</loc>
  <lastmod>2023-07-14T16:26:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Moleculin-Announces-Publication-of-Data-from-Successful-European-Phase-1-Trial-Evaluating-Annamycin-as-Single-Agent-Treatment-of-Relapsed-or-Refractory-Acute-Myeloid-Leukemia-AML</loc>
  <lastmod>2023-07-14T16:26:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Ardelyx-Announces-Acceptance-of-New-Drug-Application-for-Tenapanor-for-Hyperphosphatemia-in-China</loc>
  <lastmod>2023-07-14T16:25:25+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Ardelyx-Announces-Acceptance-of-New-Drug-Application-for-Tenapanor-for-Hyperphosphatemia-in-China</loc>
  <lastmod>2023-07-14T16:25:25+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Akari-Therapeutics-Provides-Updates-on-Development-of-Nomacopan-in-Pediatric-and-Adult-HSCT-TMA</loc>
  <lastmod>2023-07-14T16:24:36+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Akari-Therapeutics-Provides-Updates-on-Development-of-Nomacopan-in-Pediatric-and-Adult-HSCT-TMA</loc>
  <lastmod>2023-07-14T16:24:36+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Nymox-Provides-Update-on-Recent-Changes-in-Board-and-Management</loc>
  <lastmod>2023-07-14T16:23:50+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Nymox-Provides-Update-on-Recent-Changes-in-Board-and-Management</loc>
  <lastmod>2023-07-14T16:23:50+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Sirona-Biochem-Provides-Corporate-Update-July-13-2023</loc>
  <lastmod>2023-07-14T16:23:06+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Sirona-Biochem-Provides-Corporate-Update-July-13-2023</loc>
  <lastmod>2023-07-14T16:23:06+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Abu-Dhabi-Dubai-Serve-as-Gateway-to-International-Markets-for-Biopharma</loc>
  <lastmod>2023-07-14T16:22:19+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Abu-Dhabi-Dubai-Serve-as-Gateway-to-International-Markets-for-Biopharma</loc>
  <lastmod>2023-07-14T16:22:19+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Direct-Biologics-Announces-Publication-of-Significant-Survival-Benefit-with-ExoF</loc>
  <lastmod>2023-07-13T11:41:00+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Direct-Biologics-Announces-Publication-of-Significant-Survival-Benefit-with-ExoF</loc>
  <lastmod>2023-07-13T11:41:00+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/LianBio-Announces-Clinical-Supply-Agreement-with-AstraZeneca-in-China-to-Evaluate-BBP-398-in-Combination-with-Osimertinib-in-Patients-with-Non-Small-Cell-Lung-Cancer-with-EGFR-Mutations</loc>
  <lastmod>2023-07-13T10:33:52+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/LianBio-Announces-Clinical-Supply-Agreement-with-AstraZeneca-in-China-to-Evaluate-BBP-398-in-Combination-with-Osimertinib-in-Patients-with-Non-Small-Cell-Lung-Cancer-with-EGFR-Mutations</loc>
  <lastmod>2023-07-13T10:33:52+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Leap-Therapeutics-Announces-Initiation-of-Randomized-Controlled-Part-B-of-the-DeFianCe-Study-of-DKN-01-in-Colorectal-Cancer-Patients</loc>
  <lastmod>2023-07-13T10:33:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Leap-Therapeutics-Announces-Initiation-of-Randomized-Controlled-Part-B-of-the-DeFianCe-Study-of-DKN-01-in-Colorectal-Cancer-Patients</loc>
  <lastmod>2023-07-13T10:33:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/AVROBIO-to-Explore-Strategic-Alternatives</loc>
  <lastmod>2023-07-13T10:32:31+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/AVROBIO-to-Explore-Strategic-Alternatives</loc>
  <lastmod>2023-07-13T10:32:31+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Merck-KGaA-Darmstadt-Germany-Partners-with-Veeva-to-Transform-Medical-Information-Operations-Globally</loc>
  <lastmod>2023-07-13T10:31:52+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Merck-KGaA-Darmstadt-Germany-Partners-with-Veeva-to-Transform-Medical-Information-Operations-Globally</loc>
  <lastmod>2023-07-13T10:31:52+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/VICHY-Laboratoires-Partners-with-Embr-Labs-to-Bring-Clinically-Proven-Care-to-Wo</loc>
  <lastmod>2023-07-13T11:41:51+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/VICHY-Laboratoires-Partners-with-Embr-Labs-to-Bring-Clinically-Proven-Care-to-Wo</loc>
  <lastmod>2023-07-13T11:41:51+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Kamada-Announces-Two-Year-Extension-of-KEDRAB%C2%AE-Distribution-Agreement-with-Kedrion-in-the-US</loc>
  <lastmod>2023-07-13T10:30:32+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Kamada-Announces-Two-Year-Extension-of-KEDRAB%C2%AE-Distribution-Agreement-with-Kedrion-in-the-US</loc>
  <lastmod>2023-07-13T10:30:32+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/George-Medicines-Completes-Recruitment-of-First-Phase-III-Hypertension-Trial-Investigating-Novel-Single-Pill-Triple-Combination-Candidate-GMRx2</loc>
  <lastmod>2023-07-13T10:29:49+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/George-Medicines-Completes-Recruitment-of-First-Phase-III-Hypertension-Trial-Investigating-Novel-Single-Pill-Triple-Combination-Candidate-GMRx2</loc>
  <lastmod>2023-07-13T10:29:49+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Eitan-Medical-Launches-Award-Winning-Infusion-Management-Platform-Eitan-Insights</loc>
  <lastmod>2023-07-13T11:41:23+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Eitan-Medical-Launches-Award-Winning-Infusion-Management-Platform-Eitan-Insights</loc>
  <lastmod>2023-07-13T11:41:23+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/ExoCoBio-Completes-Acquisition-of-BENEV-a-Global-Medical-Aesthetic-Brand</loc>
  <lastmod>2023-07-13T10:28:22+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/ExoCoBio-Completes-Acquisition-of-BENEV-a-Global-Medical-Aesthetic-Brand</loc>
  <lastmod>2023-07-13T10:28:22+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Dr-Reddy%E2%80%99s-Proposed-Rituximab-Biosimilar-Application-Accepted-for-Review-by-USFDA-EMA-and-MHRA</loc>
  <lastmod>2023-07-13T10:27:42+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Dr-Reddy%E2%80%99s-Proposed-Rituximab-Biosimilar-Application-Accepted-for-Review-by-USFDA-EMA-and-MHRA</loc>
  <lastmod>2023-07-13T10:27:42+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Wavely-Diagnostics-Raises-135MM-in-Funding-to-Accelerate-Commercial-Launch-of-Digital-Diagnostics-Platform-for-Childhood-Ear-Infections</loc>
  <lastmod>2023-07-13T10:26:59+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Wavely-Diagnostics-Raises-135MM-in-Funding-to-Accelerate-Commercial-Launch-of-Digital-Diagnostics-Platform-for-Childhood-Ear-Infections</loc>
  <lastmod>2023-07-13T10:26:59+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Current-Surgical-Receives-400k-Grant-from-NIHs-National-Cancer-Institute-to-Develop-Surgery-Platform-for-Early-Stage-Cancer</loc>
  <lastmod>2023-07-13T10:26:19+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Current-Surgical-Receives-400k-Grant-from-NIHs-National-Cancer-Institute-to-Develop-Surgery-Platform-for-Early-Stage-Cancer</loc>
  <lastmod>2023-07-13T10:26:19+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/UAE-Saudi-Arabia-Serve-as-Gateway-to-International-Markets-for-Biopharma</loc>
  <lastmod>2023-07-13T10:25:41+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/UAE-Saudi-Arabia-Serve-as-Gateway-to-International-Markets-for-Biopharma</loc>
  <lastmod>2023-07-13T10:25:41+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Title-Seven-Biotechs-and-Biopharmas-Post-Sizable-IPOs-in-2023-Despite-Industry-Drought</loc>
  <lastmod>2023-07-13T10:25:02+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Title-Seven-Biotechs-and-Biopharmas-Post-Sizable-IPOs-in-2023-Despite-Industry-Drought</loc>
  <lastmod>2023-07-13T10:25:02+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/MaxCyte-and-Vittoria-Biotherapeutics-Sign-Strategic-Platform-License-to-Advance-Next-Generation-Cellular-Therapies</loc>
  <lastmod>2023-07-11T09:22:48+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/MaxCyte-and-Vittoria-Biotherapeutics-Sign-Strategic-Platform-License-to-Advance-Next-Generation-Cellular-Therapies</loc>
  <lastmod>2023-07-11T09:22:48+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Centessa-Pharmaceuticals-Announces-Dosing-of-First-Subject-in-Registrational-PRESent-2-Study-for-SerpinPC-in-Hemophilia-B-Treatment</loc>
  <lastmod>2023-07-11T09:22:21+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Centessa-Pharmaceuticals-Announces-Dosing-of-First-Subject-in-Registrational-PRESent-2-Study-for-SerpinPC-in-Hemophilia-B-Treatment</loc>
  <lastmod>2023-07-11T09:22:21+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/AIM-ImmunoTech-Enrolls-and-Doses-First-Subject-in-Phase-2-Study-Evaluating-Ampli</loc>
  <lastmod>2023-07-11T11:30:28+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/AIM-ImmunoTech-Enrolls-and-Doses-First-Subject-in-Phase-2-Study-Evaluating-Ampli</loc>
  <lastmod>2023-07-11T11:30:28+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Melinta-Therapeutics-Partners-with-BARDA-to-Advance-Two-FDA-Approved-Antibiotics-for-Use-in-Pediatric-Patients-and-for-Use-Against-Biothreat-Pathogens</loc>
  <lastmod>2023-07-11T09:21:24+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Melinta-Therapeutics-Partners-with-BARDA-to-Advance-Two-FDA-Approved-Antibiotics-for-Use-in-Pediatric-Patients-and-for-Use-Against-Biothreat-Pathogens</loc>
  <lastmod>2023-07-11T09:21:24+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Infinity-Pharmaceuticals-Provides-Additional-Information-on-MARIO-8-Study-Evaluating-Eganelisib-in-Combination-with-Pembrolizumab-KEYTRUDA%C2%AE</loc>
  <lastmod>2023-07-11T09:20:53+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Infinity-Pharmaceuticals-Provides-Additional-Information-on-MARIO-8-Study-Evaluating-Eganelisib-in-Combination-with-Pembrolizumab-KEYTRUDA%C2%AE</loc>
  <lastmod>2023-07-11T09:20:53+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Tango-Therapeutics-Announces-First-Patient-Dosed-in-TNG462-Phase-12-Trial-in-Patients-With-MTAP-deleted-Solid-Tumors</loc>
  <lastmod>2023-07-11T09:20:22+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Tango-Therapeutics-Announces-First-Patient-Dosed-in-TNG462-Phase-12-Trial-in-Patients-With-MTAP-deleted-Solid-Tumors</loc>
  <lastmod>2023-07-11T09:20:22+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Completion-of-Enrolment-and-Treatment-in-the-Phase-1-Study-of-MTX110-in-the-Treatment-of-Children-with-Newly-Diagnosed-Diffuse-Midline-Gliomas-DMGs</loc>
  <lastmod>2023-07-11T09:19:54+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Completion-of-Enrolment-and-Treatment-in-the-Phase-1-Study-of-MTX110-in-the-Treatment-of-Children-with-Newly-Diagnosed-Diffuse-Midline-Gliomas-DMGs</loc>
  <lastmod>2023-07-11T09:19:54+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Genelux-Corporation-Announces-Publication-of-Phase-I-Trial-Results-of-Intrapleural-Administration-of-Olvi-Vec-in-Patients-with-Malignant-Pleural-Effusion-from-Mesothelioma-Lung-or-Breast-Cancers-in-Frontiers-in-Immunology</loc>
  <lastmod>2023-07-11T09:19:26+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Genelux-Corporation-Announces-Publication-of-Phase-I-Trial-Results-of-Intrapleural-Administration-of-Olvi-Vec-in-Patients-with-Malignant-Pleural-Effusion-from-Mesothelioma-Lung-or-Breast-Cancers-in-Frontiers-in-Immunology</loc>
  <lastmod>2023-07-11T09:19:26+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Fulcrum-Therapeutics-Signs-Exclusive-Global-License-Agreement-in-Rare-Hematology-for-Diamond-Blackfan-Anemia</loc>
  <lastmod>2023-07-11T09:17:36+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Fulcrum-Therapeutics-Signs-Exclusive-Global-License-Agreement-in-Rare-Hematology-for-Diamond-Blackfan-Anemia</loc>
  <lastmod>2023-07-11T09:17:36+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Hillstream-BioPharma-Announces-Strategic-Reprioritization-of-Pipeline-to-Targeting-HER2HER3-Solid-Tumors-via-Bispecific-and-ADC-Antibodies-and-Biologics</loc>
  <lastmod>2023-07-11T09:17:08+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Hillstream-BioPharma-Announces-Strategic-Reprioritization-of-Pipeline-to-Targeting-HER2HER3-Solid-Tumors-via-Bispecific-and-ADC-Antibodies-and-Biologics</loc>
  <lastmod>2023-07-11T09:17:08+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Connect-Biopharma-Presents-Additional-Data-from-Atopic-Dermatitis-Trial-in-China-at-World-Congress-of-Dermatology</loc>
  <lastmod>2023-07-11T09:16:41+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Connect-Biopharma-Presents-Additional-Data-from-Atopic-Dermatitis-Trial-in-China-at-World-Congress-of-Dermatology</loc>
  <lastmod>2023-07-11T09:16:41+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Acceptance-of-New-Drug-Application-for-Suprachoroidal-Use-of-Arcatus%C2%AE-in-Australia</loc>
  <lastmod>2023-07-11T09:16:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Acceptance-of-New-Drug-Application-for-Suprachoroidal-Use-of-Arcatus%C2%AE-in-Australia</loc>
  <lastmod>2023-07-11T09:16:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Eloxx-Pharmaceuticals-Announces-Publication-Demonstrating-the-Power-of-its-TURBO-ZM%E2%84%A2-Platform-to-Target-the-Human-Ribosome-for-Therapeutic-Benefit</loc>
  <lastmod>2023-07-11T09:16:08+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Eloxx-Pharmaceuticals-Announces-Publication-Demonstrating-the-Power-of-its-TURBO-ZM%E2%84%A2-Platform-to-Target-the-Human-Ribosome-for-Therapeutic-Benefit</loc>
  <lastmod>2023-07-11T09:16:08+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/MIT-Professor-Cleared-of-Misconduct-After-Years-of-Scrutiny</loc>
  <lastmod>2023-07-11T09:15:16+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/MIT-Professor-Cleared-of-Misconduct-After-Years-of-Scrutiny</loc>
  <lastmod>2023-07-11T09:15:16+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/TellBio-Announces-Consecutive-Manuscripts-Showcasing-Promising-Translational-and</loc>
  <lastmod>2023-07-10T18:01:50+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/TellBio-Announces-Consecutive-Manuscripts-Showcasing-Promising-Translational-and</loc>
  <lastmod>2023-07-10T18:01:50+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Less-Than-Half-of-New-Drug-Approvals-Add-Therapeutic-Value-Over-Existing-Treatments-Study-1</loc>
  <lastmod>2023-07-10T17:46:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Less-Than-Half-of-New-Drug-Approvals-Add-Therapeutic-Value-Over-Existing-Treatments-Study-1</loc>
  <lastmod>2023-07-10T17:46:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/UMCG-in-the-Netherlands-Purchases-Micro-RayStation-for-Pre-Clinical-Research</loc>
  <lastmod>2023-07-10T18:02:29+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/UMCG-in-the-Netherlands-Purchases-Micro-RayStation-for-Pre-Clinical-Research</loc>
  <lastmod>2023-07-10T18:02:29+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Abeona-Therapeutics-Announces-Closing-of-25-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules</loc>
  <lastmod>2023-07-10T17:44:56+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Abeona-Therapeutics-Announces-Closing-of-25-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules</loc>
  <lastmod>2023-07-10T17:44:56+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/European-Patent-Granted-for-ZyVersa-Therapeutics-Lead-Asset-Cholesterol-Efflux-Mediator%E2%84%A2-VAR-200-for-Use-in-Patients-with-Diabetic-NephropathyDiabetic-Kidney-Disease</loc>
  <lastmod>2023-07-10T17:43:30+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/European-Patent-Granted-for-ZyVersa-Therapeutics-Lead-Asset-Cholesterol-Efflux-Mediator%E2%84%A2-VAR-200-for-Use-in-Patients-with-Diabetic-NephropathyDiabetic-Kidney-Disease</loc>
  <lastmod>2023-07-10T17:43:30+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/BioRestorative-Therapies-Drug-Candidate-BRTX-100-Passes-Safety-Test-With-Flying-Colors-Moves-Ahead-With-Phase-2-And-Looks-To-Expand-Pipeline-Opportunities</loc>
  <lastmod>2023-07-10T17:42:44+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/BioRestorative-Therapies-Drug-Candidate-BRTX-100-Passes-Safety-Test-With-Flying-Colors-Moves-Ahead-With-Phase-2-And-Looks-To-Expand-Pipeline-Opportunities</loc>
  <lastmod>2023-07-10T17:42:44+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Bausch-Health-Enters-Into-600-Million-Financing-Facility-With-KKR</loc>
  <lastmod>2023-07-10T17:42:07+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Bausch-Health-Enters-Into-600-Million-Financing-Facility-With-KKR</loc>
  <lastmod>2023-07-10T17:42:07+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Crystal-Pharmatech-Recognized-as-Best-Partner-by-Allorion-Therapeutics-for-Excellent-Services</loc>
  <lastmod>2023-07-11T09:10:56+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Crystal-Pharmatech-Recognized-as-Best-Partner-by-Allorion-Therapeutics-for-Excellent-Services</loc>
  <lastmod>2023-07-11T09:10:56+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/BrainStorm-Cell-Therapeutics-Data-Show-Treatment-with-NurOwn-Significantly-Reduces-NfL-a-Key-Biomarker-of-Neurodegeneration</loc>
  <lastmod>2023-07-10T17:40:47+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/BrainStorm-Cell-Therapeutics-Data-Show-Treatment-with-NurOwn-Significantly-Reduces-NfL-a-Key-Biomarker-of-Neurodegeneration</loc>
  <lastmod>2023-07-10T17:40:47+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Axsome-Therapeutics-Initiates-FOCUS-Phase-3-Trial-of-Solriamfetol-for-the-Treatment-of-Attention-Deficit-Hyperactivity-Disorder-ADHD-in-Adults</loc>
  <lastmod>2023-07-10T17:40:02+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Axsome-Therapeutics-Initiates-FOCUS-Phase-3-Trial-of-Solriamfetol-for-the-Treatment-of-Attention-Deficit-Hyperactivity-Disorder-ADHD-in-Adults</loc>
  <lastmod>2023-07-10T17:40:02+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Roche%E2%80%99s-Tecentriq-Improves-Survival-in-Ineligible-NSCLC-Patients</loc>
  <lastmod>2023-07-10T17:39:23+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Roche%E2%80%99s-Tecentriq-Improves-Survival-in-Ineligible-NSCLC-Patients</loc>
  <lastmod>2023-07-10T17:39:23+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Broncus-Completes-First-Case-of-Registered-Clinical-Trials-for-Targeted-Lung-Denervation-Radiofrequency-Ablation-System</loc>
  <lastmod>2023-07-10T17:41:50+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Broncus-Completes-First-Case-of-Registered-Clinical-Trials-for-Targeted-Lung-Denervation-Radiofrequency-Ablation-System</loc>
  <lastmod>2023-07-10T17:41:50+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/HUTCHMED-Initiates-Phase-I-Study-of-SHP2-Inhibitor-HMPL-415-for-Advanced-Malignant-Solid-Tumors-in-China</loc>
  <lastmod>2023-07-10T17:40:20+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/HUTCHMED-Initiates-Phase-I-Study-of-SHP2-Inhibitor-HMPL-415-for-Advanced-Malignant-Solid-Tumors-in-China</loc>
  <lastmod>2023-07-10T17:40:20+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Biophytis-Files-for-FDA-Authorization-to-Begin-Phase-3-Study-in-Sarcopenia</loc>
  <lastmod>2023-07-10T17:37:23+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Biophytis-Files-for-FDA-Authorization-to-Begin-Phase-3-Study-in-Sarcopenia</loc>
  <lastmod>2023-07-10T17:37:23+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Roches-Tecentriq-Improves-Survival-in-NSCLC-Patients-Ineligible-for-Platinum-Chemo</loc>
  <lastmod>2023-07-08T18:54:22+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Roches-Tecentriq-Improves-Survival-in-NSCLC-Patients-Ineligible-for-Platinum-Chemo</loc>
  <lastmod>2023-07-08T18:54:22+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Phil-Inc-Partners-with-RedHill-Biopharma-to-Increase-Access-to-Talicia%C2%AE</loc>
  <lastmod>2023-07-07T10:50:34+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Phil-Inc-Partners-with-RedHill-Biopharma-to-Increase-Access-to-Talicia%C2%AE</loc>
  <lastmod>2023-07-07T10:50:34+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Publication-of-Manuscript-from-the-PNOC015-aka-MTD-201-Study-in-Patients-with-Diffuse-Midline-Glioma-DMG</loc>
  <lastmod>2023-07-07T10:01:50+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Publication-of-Manuscript-from-the-PNOC015-aka-MTD-201-Study-in-Patients-with-Diffuse-Midline-Glioma-DMG</loc>
  <lastmod>2023-07-07T10:01:50+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Secarna-Pharmaceuticals-Demonstrates-Therapeutic-Activity-of-LNAplus%E2%84%A2-ASO-Targeting-NLRP3-in-Autoinflammatory-Diseases</loc>
  <lastmod>2023-07-07T10:01:44+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Secarna-Pharmaceuticals-Demonstrates-Therapeutic-Activity-of-LNAplus%E2%84%A2-ASO-Targeting-NLRP3-in-Autoinflammatory-Diseases</loc>
  <lastmod>2023-07-07T10:01:44+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Shorla-Oncology-Announces-Licensing-Agreement-and-Strategic-Partnership-for-Rights-to-Market-Chemotherapy-Drug-PIP-101-in-the-United-States</loc>
  <lastmod>2023-07-07T09:59:33+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Shorla-Oncology-Announces-Licensing-Agreement-and-Strategic-Partnership-for-Rights-to-Market-Chemotherapy-Drug-PIP-101-in-the-United-States</loc>
  <lastmod>2023-07-07T09:59:33+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Incannex-Receives-Ethics-Approval-for-BioequivalenceBioavailability-Clinical-Trial-for-IHL-42X-the-Company%E2%80%99s-Proprietary-Drug-for-Treatment-of-Obstructive-Sleep-Apnoea-%E2%80%98OSA%E2%80%99</loc>
  <lastmod>2023-07-07T09:59:02+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Incannex-Receives-Ethics-Approval-for-BioequivalenceBioavailability-Clinical-Trial-for-IHL-42X-the-Company%E2%80%99s-Proprietary-Drug-for-Treatment-of-Obstructive-Sleep-Apnoea-%E2%80%98OSA%E2%80%99</loc>
  <lastmod>2023-07-07T09:59:02+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Hillstream-BioPharma-Licenses-Technology-to-Develop-Proprietary-HER2-and-HER3-Antibody-Drug-Conjugates-against-Drug-Resistant-Breast-Lung-Gastric-and-Ovarian-Cancers</loc>
  <lastmod>2023-07-07T10:05:07+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Hillstream-BioPharma-Licenses-Technology-to-Develop-Proprietary-HER2-and-HER3-Antibody-Drug-Conjugates-against-Drug-Resistant-Breast-Lung-Gastric-and-Ovarian-Cancers</loc>
  <lastmod>2023-07-07T10:05:07+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Simcha-Therapeutics-Announces-First-Patient-Dosed-in-Phase-12-Study-Evaluating-ST-067-in-Combination-with-KEYTRUDA%C2%AE-Pembrolizumab-in-Patients-with-Various-Solid-Tumors</loc>
  <lastmod>2023-07-07T09:58:16+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Simcha-Therapeutics-Announces-First-Patient-Dosed-in-Phase-12-Study-Evaluating-ST-067-in-Combination-with-KEYTRUDA%C2%AE-Pembrolizumab-in-Patients-with-Various-Solid-Tumors</loc>
  <lastmod>2023-07-07T09:58:16+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/FDA-Removes-Partial-Clinical-Hold-on-TakeAim-Leukemia-Study-RP2D-Established-at-300-mg-BID</loc>
  <lastmod>2023-07-07T09:57:45+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/FDA-Removes-Partial-Clinical-Hold-on-TakeAim-Leukemia-Study-RP2D-Established-at-300-mg-BID</loc>
  <lastmod>2023-07-07T09:57:45+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Carrick-Therapeutics-Announces-Clinical-Trial-Collaboration-with-Arvinas-and-Pfizer-to-Evaluate-Samuraciclib-and-Vepdegestrant-Combination</loc>
  <lastmod>2023-07-07T10:06:36+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Carrick-Therapeutics-Announces-Clinical-Trial-Collaboration-with-Arvinas-and-Pfizer-to-Evaluate-Samuraciclib-and-Vepdegestrant-Combination</loc>
  <lastmod>2023-07-07T10:06:36+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Vaxart-Announces-Positive-Preliminary-Topline-Data-from-Dose-Ranging-Phase-2-Study-of-its-Bivalent-Norovirus-Vaccine-Candidate</loc>
  <lastmod>2023-07-07T09:56:40+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Vaxart-Announces-Positive-Preliminary-Topline-Data-from-Dose-Ranging-Phase-2-Study-of-its-Bivalent-Norovirus-Vaccine-Candidate</loc>
  <lastmod>2023-07-07T09:56:40+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/CoImmune-Announces-Publication-of-Review-of-Clinical-Development-Program-for-CMN-001-in-Metastatic-Renal-Cell-Carcinoma</loc>
  <lastmod>2023-07-07T09:56:05+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/CoImmune-Announces-Publication-of-Review-of-Clinical-Development-Program-for-CMN-001-in-Metastatic-Renal-Cell-Carcinoma</loc>
  <lastmod>2023-07-07T09:56:05+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Celldex-Announces-First-Patient-Dosed-in-Phase-2-Study-of-Barzolvolimab-in-Eosinophilic-Esophagitis</loc>
  <lastmod>2023-07-07T09:55:33+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Celldex-Announces-First-Patient-Dosed-in-Phase-2-Study-of-Barzolvolimab-in-Eosinophilic-Esophagitis</loc>
  <lastmod>2023-07-07T09:55:33+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Ultragenyx-Announces-First-Patients-Dosed-in-Phase-3-Program-Evaluating-Setrusumab-UX143-for-the-Treatment-of-Osteogenesis-Imperfecta-OI</loc>
  <lastmod>2023-07-07T09:55:01+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Ultragenyx-Announces-First-Patients-Dosed-in-Phase-3-Program-Evaluating-Setrusumab-UX143-for-the-Treatment-of-Osteogenesis-Imperfecta-OI</loc>
  <lastmod>2023-07-07T09:55:01+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/TellBio-Announces-Consecutive-Manuscripts-Demonstrating-Translational-and-Clinical-Applications-of-the-TellDx-Platform-in-Prostate-Cancer-and-Advanced-Breast-Cancer</loc>
  <lastmod>2023-07-07T09:56:09+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/TellBio-Announces-Consecutive-Manuscripts-Demonstrating-Translational-and-Clinical-Applications-of-the-TellDx-Platform-in-Prostate-Cancer-and-Advanced-Breast-Cancer</loc>
  <lastmod>2023-07-07T09:56:09+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Less-Than-Half-of-New-Drug-Approvals-Add-Therapeutic-Value-Over-Existing-Treatments-Study</loc>
  <lastmod>2023-07-07T09:55:44+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Less-Than-Half-of-New-Drug-Approvals-Add-Therapeutic-Value-Over-Existing-Treatments-Study</loc>
  <lastmod>2023-07-07T09:55:44+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/New-Scientific-Research-Funding-Available-to-Eliminate-Pre-Term-Deliveries-from-Preeclampsia</loc>
  <lastmod>2023-07-06T09:15:31+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/New-Scientific-Research-Funding-Available-to-Eliminate-Pre-Term-Deliveries-from-Preeclampsia</loc>
  <lastmod>2023-07-06T09:15:31+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Korea-University-Medicine-Study-Identifies-a-New-Biomarker-for-Major-Depressive-Disorder</loc>
  <lastmod>2023-07-06T16:04:14+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Korea-University-Medicine-Study-Identifies-a-New-Biomarker-for-Major-Depressive-Disorder</loc>
  <lastmod>2023-07-06T16:04:14+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Altamira-Therapeutics-Announces-Collaboration-with-Heqet-Therapeutics-on-Nanoparticle-Delivered-Non-Coding-RNAs-for-Cardiac-Regeneration</loc>
  <lastmod>2023-07-06T09:14:04+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Altamira-Therapeutics-Announces-Collaboration-with-Heqet-Therapeutics-on-Nanoparticle-Delivered-Non-Coding-RNAs-for-Cardiac-Regeneration</loc>
  <lastmod>2023-07-06T09:14:04+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Palisade-Bio-Announces-Completion-of-Enrollment-in-LB1148-Dose-Optimization-Study</loc>
  <lastmod>2023-07-06T09:13:38+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Palisade-Bio-Announces-Completion-of-Enrollment-in-LB1148-Dose-Optimization-Study</loc>
  <lastmod>2023-07-06T09:13:38+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Sorrento-Announces-Positive-Phase-IIa-Study-Results-of-Abivertinib-for-the-Treatment-of-RelapsedRefractory-Marginal-Zone-Lymphoma-RR-MZL-and-Its-Plan-for-a-Pivotal-Phase-III-Study</loc>
  <lastmod>2023-07-06T09:13:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Sorrento-Announces-Positive-Phase-IIa-Study-Results-of-Abivertinib-for-the-Treatment-of-RelapsedRefractory-Marginal-Zone-Lymphoma-RR-MZL-and-Its-Plan-for-a-Pivotal-Phase-III-Study</loc>
  <lastmod>2023-07-06T09:13:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Propanc-Biopharma-Produces-Synthetic-Recombinant-Proenzymes-for-Cancer-Therapy-Targeting-Advanced-Solid-Tumors</loc>
  <lastmod>2023-07-06T09:12:28+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Propanc-Biopharma-Produces-Synthetic-Recombinant-Proenzymes-for-Cancer-Therapy-Targeting-Advanced-Solid-Tumors</loc>
  <lastmod>2023-07-06T09:12:28+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Kleine-Levin-Syndrome-Foundation-Announces-Updated-Diagnostic-Criteria-for-KLS</loc>
  <lastmod>2023-07-06T09:10:47+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Kleine-Levin-Syndrome-Foundation-Announces-Updated-Diagnostic-Criteria-for-KLS</loc>
  <lastmod>2023-07-06T09:10:47+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Liberate-Medical-Secures-62M-in-Series-B-Financing</loc>
  <lastmod>2023-07-06T09:10:19+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Liberate-Medical-Secures-62M-in-Series-B-Financing</loc>
  <lastmod>2023-07-06T09:10:19+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Acasti-Announces-Alignment-with-FDA-on-GTX-104-Pivotal-Phase-3-Safety-Trial-Protocol-and-Confirms-Planned-Initiation-of-STRIVE-ON-in-aSAH-Patients-in-Calendar-Q4-2023</loc>
  <lastmod>2023-07-06T09:09:50+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Acasti-Announces-Alignment-with-FDA-on-GTX-104-Pivotal-Phase-3-Safety-Trial-Protocol-and-Confirms-Planned-Initiation-of-STRIVE-ON-in-aSAH-Patients-in-Calendar-Q4-2023</loc>
  <lastmod>2023-07-06T09:09:50+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Ayala-Pharmaceuticals-Announces-Successful-End-of-Phase-2-Meeting-with-FDA-Regarding-AL102-for-the-Treatment-of-Desmoid-Tumors</loc>
  <lastmod>2023-07-06T09:08:58+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Ayala-Pharmaceuticals-Announces-Successful-End-of-Phase-2-Meeting-with-FDA-Regarding-AL102-for-the-Treatment-of-Desmoid-Tumors</loc>
  <lastmod>2023-07-06T09:08:58+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/F-star-Announces-Strategic-Collaboration-and-Licence-Agreement-with-Takeda-to-Develop-Next-Generation-Multi-Specific-Antibodies</loc>
  <lastmod>2023-07-06T09:08:59+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/F-star-Announces-Strategic-Collaboration-and-Licence-Agreement-with-Takeda-to-Develop-Next-Generation-Multi-Specific-Antibodies</loc>
  <lastmod>2023-07-06T09:08:59+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/InnoCare-Announces-First-Psoriasis-Patient-Dosed-in-Clinical-Trial-of-TYK2-Allosteric-Inhibitor-ICP-488-in-China-1</loc>
  <lastmod>2023-07-06T09:08:04+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/InnoCare-Announces-First-Psoriasis-Patient-Dosed-in-Clinical-Trial-of-TYK2-Allosteric-Inhibitor-ICP-488-in-China-1</loc>
  <lastmod>2023-07-06T09:08:04+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Daxor-Corporation-Awarded-11-Million-Contract-from-the-United-States-Defense-Health-Agency-for-Added-Capabilities-to-its-Point-of-Care-Blood-Volume-Analyzer</loc>
  <lastmod>2023-07-06T09:08:31+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Daxor-Corporation-Awarded-11-Million-Contract-from-the-United-States-Defense-Health-Agency-for-Added-Capabilities-to-its-Point-of-Care-Blood-Volume-Analyzer</loc>
  <lastmod>2023-07-06T09:08:31+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Simufilam-Slowed-Cognitive-Decline-in-a-Randomized-Withdrawal-Trial-of-Mild-to-Moderate-Alzheimer%E2%80%99s-Disease</loc>
  <lastmod>2023-07-06T09:07:10+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Simufilam-Slowed-Cognitive-Decline-in-a-Randomized-Withdrawal-Trial-of-Mild-to-Moderate-Alzheimer%E2%80%99s-Disease</loc>
  <lastmod>2023-07-06T09:07:10+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Positive-Aggregate-Safety-Data-From-Vafidemstat%E2%80%99s-Ongoing-Phase-IIb-PORTICO-Trial-in-Borderline-Personality-Disorder</loc>
  <lastmod>2023-07-06T09:08:00+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Positive-Aggregate-Safety-Data-From-Vafidemstat%E2%80%99s-Ongoing-Phase-IIb-PORTICO-Trial-in-Borderline-Personality-Disorder</loc>
  <lastmod>2023-07-06T09:08:00+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/InnoCare-Announces-First-Psoriasis-Patient-Dosed-in-Clinical-Trial-of-TYK2-Allosteric-Inhibitor-ICP-488-in-China</loc>
  <lastmod>2023-07-05T15:06:32+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/InnoCare-Announces-First-Psoriasis-Patient-Dosed-in-Clinical-Trial-of-TYK2-Allosteric-Inhibitor-ICP-488-in-China</loc>
  <lastmod>2023-07-05T15:06:32+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Lunits-AI-Powered-Lung-Cancer-Screening-Solution-Significantly-Affects-Radiologists-Diagnostic-Determination</loc>
  <lastmod>2023-07-05T12:24:10+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Lunits-AI-Powered-Lung-Cancer-Screening-Solution-Significantly-Affects-Radiologists-Diagnostic-Determination</loc>
  <lastmod>2023-07-05T12:24:10+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/CANbridge-to-Continue-CAN008-Phase-2-Trial-in-Glioblastoma-Multiforme-GBM-in-China-Based-on-Interim-Analysis-of-Independent-Data-Monitoring-Committee</loc>
  <lastmod>2023-07-04T15:33:35+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/CANbridge-to-Continue-CAN008-Phase-2-Trial-in-Glioblastoma-Multiforme-GBM-in-China-Based-on-Interim-Analysis-of-Independent-Data-Monitoring-Committee</loc>
  <lastmod>2023-07-04T15:33:35+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Title-Journey-Medical-Corporation-Expects-Topline-Results-from-Phase-3-Clinical-Trials-Evaluating-DFD-29-for-the-Treatment-of-Rosacea</loc>
  <lastmod>2023-07-05T22:44:32+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Title-Journey-Medical-Corporation-Expects-Topline-Results-from-Phase-3-Clinical-Trials-Evaluating-DFD-29-for-the-Treatment-of-Rosacea</loc>
  <lastmod>2023-07-05T22:44:32+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Abeona-Therapeutics-Announces-25-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules</loc>
  <lastmod>2023-07-05T11:53:20+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Abeona-Therapeutics-Announces-25-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules</loc>
  <lastmod>2023-07-05T11:53:20+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/NLS-Pharmaceutics-to-Proceed-with-Phase-3-Clinical-Program-AMAZE-for-Mazindol-ER-for-the-Treatment-of-Narcolepsy-Following-FDA-Review-and-IRB-Approval-of-the-Full-Study-Protocol</loc>
  <lastmod>2023-07-04T15:32:08+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/NLS-Pharmaceutics-to-Proceed-with-Phase-3-Clinical-Program-AMAZE-for-Mazindol-ER-for-the-Treatment-of-Narcolepsy-Following-FDA-Review-and-IRB-Approval-of-the-Full-Study-Protocol</loc>
  <lastmod>2023-07-04T15:32:08+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Datopotamab-Deruxtecan-Demonstrates-Progression-Free-Survival-in-Advanced-Non-Small-Cell-Lung-Cancer</loc>
  <lastmod>2023-07-04T15:31:39+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Datopotamab-Deruxtecan-Demonstrates-Progression-Free-Survival-in-Advanced-Non-Small-Cell-Lung-Cancer</loc>
  <lastmod>2023-07-04T15:31:39+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Fresenius-Kabi-Introduces-IDACIO%C2%AE-adalimumab-aacf-as-its-First-Immunology-Biosimilar-in-the-United-States</loc>
  <lastmod>2023-07-04T15:31:34+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Fresenius-Kabi-Introduces-IDACIO%C2%AE-adalimumab-aacf-as-its-First-Immunology-Biosimilar-in-the-United-States</loc>
  <lastmod>2023-07-04T15:31:34+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Labcorp-Completes-Spin-off-of-Fortrea</loc>
  <lastmod>2023-07-04T15:30:36+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Labcorp-Completes-Spin-off-of-Fortrea</loc>
  <lastmod>2023-07-04T15:30:36+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Skyline-Therapeutics-Receives-FDA-Clearance-of-IND-for-SKG0106-a-Novel-Intravitreally-Delivered-AAV-Gene-Therapy-Candidate-for-Neovascular-Age-related-Macular-Degeneration</loc>
  <lastmod>2023-07-04T15:30:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Skyline-Therapeutics-Receives-FDA-Clearance-of-IND-for-SKG0106-a-Novel-Intravitreally-Delivered-AAV-Gene-Therapy-Candidate-for-Neovascular-Age-related-Macular-Degeneration</loc>
  <lastmod>2023-07-04T15:30:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/National-Cancer-Center-Announces-Recipients-of-2023-24-Research-Fellowship-Awards</loc>
  <lastmod>2023-07-03T10:18:20+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/National-Cancer-Center-Announces-Recipients-of-2023-24-Research-Fellowship-Awards</loc>
  <lastmod>2023-07-03T10:18:20+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Aquestive-Therapeutics-Provides-Business-Update-and-Announces-Chief-Medical-Officer-Appointment</loc>
  <lastmod>2023-07-02T00:17:18+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Aquestive-Therapeutics-Provides-Business-Update-and-Announces-Chief-Medical-Officer-Appointment</loc>
  <lastmod>2023-07-02T00:17:18+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Corvus-Pharmaceuticals-Presents-New-Ciforadenant-Preclinical-Data-at-the-2nd-JCA-AACR-Precision-Cancer-Medicine-International-Conference</loc>
  <lastmod>2023-07-02T00:16:37+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Corvus-Pharmaceuticals-Presents-New-Ciforadenant-Preclinical-Data-at-the-2nd-JCA-AACR-Precision-Cancer-Medicine-International-Conference</loc>
  <lastmod>2023-07-02T00:16:37+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Positive-Interim-Updates-from-ReSPECT%E2%84%A2-Clinical-Trials-Presented-at-SNMMI-Annual-Meeting</loc>
  <lastmod>2023-07-02T00:15:57+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Positive-Interim-Updates-from-ReSPECT%E2%84%A2-Clinical-Trials-Presented-at-SNMMI-Annual-Meeting</loc>
  <lastmod>2023-07-02T00:15:57+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Harbour-BioMed-Announces-Biologics-License-Application-Acceptance-of-Batoclimab-for-Treatment-of-Generalized-Myasthenia-Gravis-by-NMPA</loc>
  <lastmod>2023-07-02T00:15:15+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Harbour-BioMed-Announces-Biologics-License-Application-Acceptance-of-Batoclimab-for-Treatment-of-Generalized-Myasthenia-Gravis-by-NMPA</loc>
  <lastmod>2023-07-02T00:15:15+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Microbot-Medical-Successfully-Completes-Pre-Clinical-Study-with-LIBERTY-Robotic-Surgical-System</loc>
  <lastmod>2023-07-02T00:14:32+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Microbot-Medical-Successfully-Completes-Pre-Clinical-Study-with-LIBERTY-Robotic-Surgical-System</loc>
  <lastmod>2023-07-02T00:14:32+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/SK-Bioscience-and-Sanofi-Announce-Positive-Results-from-Phase-II-Study-of-21-Valent-Pneumococcal-Conjugate-Vaccine-Candidate</loc>
  <lastmod>2023-07-02T00:13:55+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/SK-Bioscience-and-Sanofi-Announce-Positive-Results-from-Phase-II-Study-of-21-Valent-Pneumococcal-Conjugate-Vaccine-Candidate</loc>
  <lastmod>2023-07-02T00:13:55+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Osemitamab-TST001-plus-CAPOX-as-the-First-Line-Treatment-of-Advanced-GGEJ-Cancer-%E2%80%93-Updated-Efficacy-Data-per-Claudin-182-Expression-Level-from-Study-TranStar102TST001-1002-Cohort-C</loc>
  <lastmod>2023-07-02T00:13:15+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Osemitamab-TST001-plus-CAPOX-as-the-First-Line-Treatment-of-Advanced-GGEJ-Cancer-%E2%80%93-Updated-Efficacy-Data-per-Claudin-182-Expression-Level-from-Study-TranStar102TST001-1002-Cohort-C</loc>
  <lastmod>2023-07-02T00:13:15+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/FSD-Pharma-Inc-Announces-Results-of-Annual-General-and-Special-Meeting-of-Shareholders</loc>
  <lastmod>2023-07-02T00:12:34+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/FSD-Pharma-Inc-Announces-Results-of-Annual-General-and-Special-Meeting-of-Shareholders</loc>
  <lastmod>2023-07-02T00:12:34+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Study-Shows-DecisionDx-Melanoma-Provides-Prognostic-Information-on-Survival-Outcomes</loc>
  <lastmod>2023-07-02T00:11:54+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Study-Shows-DecisionDx-Melanoma-Provides-Prognostic-Information-on-Survival-Outcomes</loc>
  <lastmod>2023-07-02T00:11:54+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/New-Dosing-Schedule-for-Ropeginterferon-Alfa-2b-Shows-Improved-Efficacy-in-Polycythemia-Vera</loc>
  <lastmod>2023-07-02T00:11:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/New-Dosing-Schedule-for-Ropeginterferon-Alfa-2b-Shows-Improved-Efficacy-in-Polycythemia-Vera</loc>
  <lastmod>2023-07-02T00:11:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Delta-Fly-Pharma-Inc-Provides-Schedule-for-Interim-Analysis-of-Phase-3-Study-of-DFP-10917-in-RR-AML</loc>
  <lastmod>2023-07-06T20:23:38+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Delta-Fly-Pharma-Inc-Provides-Schedule-for-Interim-Analysis-of-Phase-3-Study-of-DFP-10917-in-RR-AML</loc>
  <lastmod>2023-07-06T20:23:38+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Madrigal-Pharmaceuticals-Initiates-Rolling-Submission-of-New-Drug-Application-for-Resmetirom-to-FDA-for-NASH-Treatment</loc>
  <lastmod>2023-07-02T00:09:53+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Madrigal-Pharmaceuticals-Initiates-Rolling-Submission-of-New-Drug-Application-for-Resmetirom-to-FDA-for-NASH-Treatment</loc>
  <lastmod>2023-07-02T00:09:53+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/AEON-Biopharma-and-Priveterra-Announce-Arrangement-of-Up-to-125-Million-of-Financing-in-Connection-with-Proposed-Business-Combination</loc>
  <lastmod>2023-07-02T00:09:10+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/AEON-Biopharma-and-Priveterra-Announce-Arrangement-of-Up-to-125-Million-of-Financing-in-Connection-with-Proposed-Business-Combination</loc>
  <lastmod>2023-07-02T00:09:10+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/SciSparc-Receives-Approval-for-Phase-IIb-Clinical-Trial-of-SCI-110-to-Treat-Tourette-Syndrome-in-Germany</loc>
  <lastmod>2023-07-02T00:08:28+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/SciSparc-Receives-Approval-for-Phase-IIb-Clinical-Trial-of-SCI-110-to-Treat-Tourette-Syndrome-in-Germany</loc>
  <lastmod>2023-07-02T00:08:28+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Aurora-Spine-Announces-Initial-Patient-Enrolled-for-DEXA-CTM-Multicenter-Study</loc>
  <lastmod>2023-06-29T09:31:01+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Aurora-Spine-Announces-Initial-Patient-Enrolled-for-DEXA-CTM-Multicenter-Study</loc>
  <lastmod>2023-06-29T09:31:01+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Cognition-Therapeutics-Announces-Positive-Topline-Results-for-CT1812-Phase-2-SEQUEL-Study-for-Mild-to-Moderate-Alzheimer%E2%80%99s-Disease</loc>
  <lastmod>2023-06-29T09:30:23+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Cognition-Therapeutics-Announces-Positive-Topline-Results-for-CT1812-Phase-2-SEQUEL-Study-for-Mild-to-Moderate-Alzheimer%E2%80%99s-Disease</loc>
  <lastmod>2023-06-29T09:30:23+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Foghorn-Therapeutics-Announces-Clinical-Data-from-Phase-1-Study-of-FHD-286-in-Metastatic-Uveal-Melanoma</loc>
  <lastmod>2023-06-29T09:29:42+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Foghorn-Therapeutics-Announces-Clinical-Data-from-Phase-1-Study-of-FHD-286-in-Metastatic-Uveal-Melanoma</loc>
  <lastmod>2023-06-29T09:29:42+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/First-Wave-BioPharma-Announces-Final-Patient-Dosed-in-Phase-2-SPAN-Clinical-Trial-of-Enhanced-Adrulipase-Formulation</loc>
  <lastmod>2023-06-29T09:29:05+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/First-Wave-BioPharma-Announces-Final-Patient-Dosed-in-Phase-2-SPAN-Clinical-Trial-of-Enhanced-Adrulipase-Formulation</loc>
  <lastmod>2023-06-29T09:29:05+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Chemomab-Therapeutics-Announces-Publication-in-JCI-Insight-Demonstrating-Key-Role-of-CCL24-in-Primary-Sclerosing-Cholangitis</loc>
  <lastmod>2023-06-29T09:28:25+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Chemomab-Therapeutics-Announces-Publication-in-JCI-Insight-Demonstrating-Key-Role-of-CCL24-in-Primary-Sclerosing-Cholangitis</loc>
  <lastmod>2023-06-29T09:28:25+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Taysha-Gene-Therapies-Provides-Clinical-Updates-for-Investigational-Programs-TSHA-120-in-Giant-Axonal-Neuropathy-GAN-and-TSHA-102-in-Rett-Syndrome-at-RD-Day</loc>
  <lastmod>2023-06-29T08:40:54+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Taysha-Gene-Therapies-Provides-Clinical-Updates-for-Investigational-Programs-TSHA-120-in-Giant-Axonal-Neuropathy-GAN-and-TSHA-102-in-Rett-Syndrome-at-RD-Day</loc>
  <lastmod>2023-06-29T08:40:54+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Viracta-Therapeutics-NAVAL-1-Trial-Achieves-Efficacy-Threshold-for-Expansion-in-Relapsed-or-Refractory-EBV-positive-Peripheral-T-Cell-Lymphoma</loc>
  <lastmod>2023-06-29T08:40:11+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Viracta-Therapeutics-NAVAL-1-Trial-Achieves-Efficacy-Threshold-for-Expansion-in-Relapsed-or-Refractory-EBV-positive-Peripheral-T-Cell-Lymphoma</loc>
  <lastmod>2023-06-29T08:40:11+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Atossa-Therapeutics-and-Quantum-Leap-Healthcare-Provide-Enrollment-Update-for-Z-Endoxifen-Arm-of-Ongoing-I-SPY-2-Clinical-Trial</loc>
  <lastmod>2023-06-29T08:39:34+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Atossa-Therapeutics-and-Quantum-Leap-Healthcare-Provide-Enrollment-Update-for-Z-Endoxifen-Arm-of-Ongoing-I-SPY-2-Clinical-Trial</loc>
  <lastmod>2023-06-29T08:39:34+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Susan-G-Komen%C2%AE-Announces-2023-Grants-to-Accelerate-Research-Discoveries-and-Improve-Outcomes-for-Breast-Cancer-Patients</loc>
  <lastmod>2023-06-29T08:38:58+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Susan-G-Komen%C2%AE-Announces-2023-Grants-to-Accelerate-Research-Discoveries-and-Improve-Outcomes-for-Breast-Cancer-Patients</loc>
  <lastmod>2023-06-29T08:38:58+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Eloxx-Pharmaceuticals-Highlights-Unmet-Need-in-Treatment-of-Alport-Syndrome-Patients-with-Nonsense-Mutations-and-Positive-Phase-2-Results-for-ELX-02</loc>
  <lastmod>2023-06-29T08:38:22+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Eloxx-Pharmaceuticals-Highlights-Unmet-Need-in-Treatment-of-Alport-Syndrome-Patients-with-Nonsense-Mutations-and-Positive-Phase-2-Results-for-ELX-02</loc>
  <lastmod>2023-06-29T08:38:22+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Sirona-Biochem-Advances-Antiviral-Research-with-New-Compound-Candidates-for-Testing-at-the-ICGEB</loc>
  <lastmod>2023-06-29T08:37:47+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Sirona-Biochem-Advances-Antiviral-Research-with-New-Compound-Candidates-for-Testing-at-the-ICGEB</loc>
  <lastmod>2023-06-29T08:37:47+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Edesa-Biotechs-Paridiprubart-Shows-Promise-in-Inhibiting-Inflammation-from-Influenza-and-Other-Pathogens</loc>
  <lastmod>2023-06-29T08:37:11+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Edesa-Biotechs-Paridiprubart-Shows-Promise-in-Inhibiting-Inflammation-from-Influenza-and-Other-Pathogens</loc>
  <lastmod>2023-06-29T08:37:11+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/ZyVersa-Therapeutics-Announces-Publication-in-Clinical-Immunology-Demonstrating-Association-Between-Renal-NLRP3-Inflammasome-Activation-and-Lupus-Nephritis-Disease-Activity</loc>
  <lastmod>2023-06-29T08:36:31+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/ZyVersa-Therapeutics-Announces-Publication-in-Clinical-Immunology-Demonstrating-Association-Between-Renal-NLRP3-Inflammasome-Activation-and-Lupus-Nephritis-Disease-Activity</loc>
  <lastmod>2023-06-29T08:36:31+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Celmatix-Announces-Breakthrough-in-Novel-Oral-Fertility-Drug-Program</loc>
  <lastmod>2023-06-28T13:23:08+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Celmatix-Announces-Breakthrough-in-Novel-Oral-Fertility-Drug-Program</loc>
  <lastmod>2023-06-28T13:23:08+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Augmedics-Raises-825-Million-to-Accelerate-Adoption-of-Augmented-Reality-Spine-Surgery</loc>
  <lastmod>2023-06-28T13:22:23+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Augmedics-Raises-825-Million-to-Accelerate-Adoption-of-Augmented-Reality-Spine-Surgery</loc>
  <lastmod>2023-06-28T13:22:23+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Thermo-Fisher-Scientific-Introduces-New-Generation-Fully-Automated-STEM-Metrology-Solution-for-Semiconductor-Manufacturing</loc>
  <lastmod>2023-06-28T13:21:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Thermo-Fisher-Scientific-Introduces-New-Generation-Fully-Automated-STEM-Metrology-Solution-for-Semiconductor-Manufacturing</loc>
  <lastmod>2023-06-28T13:21:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/DNAnexus-Platform-Enables-Researchers-to-Access-and-Analyze-Biomedical-Data-for-Largest-Health-Research-Program-in-Mexico</loc>
  <lastmod>2023-06-28T13:21:06+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/DNAnexus-Platform-Enables-Researchers-to-Access-and-Analyze-Biomedical-Data-for-Largest-Health-Research-Program-in-Mexico</loc>
  <lastmod>2023-06-28T13:21:06+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Freya-Biosciences-Announces-Positive-Topline-Clinical-Trial-Results-for-FB101-in-Women-with-Asymptomatic-Vaginal-Dysbiosis</loc>
  <lastmod>2023-06-28T13:20:21+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Freya-Biosciences-Announces-Positive-Topline-Clinical-Trial-Results-for-FB101-in-Women-with-Asymptomatic-Vaginal-Dysbiosis</loc>
  <lastmod>2023-06-28T13:20:21+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Lovell-and-Freespira-Increase-Access-to-FDA-Cleared-Drug-Free-PTSD-Treatment-for-Veterans-and-Military-Personnel</loc>
  <lastmod>2023-06-28T13:19:36+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Lovell-and-Freespira-Increase-Access-to-FDA-Cleared-Drug-Free-PTSD-Treatment-for-Veterans-and-Military-Personnel</loc>
  <lastmod>2023-06-28T13:19:36+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/City-of-Hope-Presents-New-Research-on-Beta-Cells-Insulin-Secretion-and-Islet-Transplantation-at-ADA-Conference</loc>
  <lastmod>2023-06-28T13:18:53+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/City-of-Hope-Presents-New-Research-on-Beta-Cells-Insulin-Secretion-and-Islet-Transplantation-at-ADA-Conference</loc>
  <lastmod>2023-06-28T13:18:53+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/SK-Bioscience-and-the-Peter-Doherty-Institute-for-Infection-and-Immunity-Join-Forces-Against-Influenza</loc>
  <lastmod>2023-06-28T13:18:09+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/SK-Bioscience-and-the-Peter-Doherty-Institute-for-Infection-and-Immunity-Join-Forces-Against-Influenza</loc>
  <lastmod>2023-06-28T13:18:09+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Inozyme-Pharma-Announces-Dosing-of-First-Infant-with-ENPP1-Deficiency-in-a-Phase-1b-Trial-of-INZ-701</loc>
  <lastmod>2023-06-28T13:14:15+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Inozyme-Pharma-Announces-Dosing-of-First-Infant-with-ENPP1-Deficiency-in-a-Phase-1b-Trial-of-INZ-701</loc>
  <lastmod>2023-06-28T13:14:15+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Oncocyte-Begins-Manufacturing-Transplant-Blood-Test</loc>
  <lastmod>2023-06-28T13:13:32+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Oncocyte-Begins-Manufacturing-Transplant-Blood-Test</loc>
  <lastmod>2023-06-28T13:13:32+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/APX3330-ZETA-1-Clinical-Data-Presented-at-American-Diabetes-Association%E2%80%99s-Annual-Conference</loc>
  <lastmod>2023-06-28T13:12:53+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/APX3330-ZETA-1-Clinical-Data-Presented-at-American-Diabetes-Association%E2%80%99s-Annual-Conference</loc>
  <lastmod>2023-06-28T13:12:53+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/First-Wave-BioPharma-Strengthens-Intellectual-Property-Estate</loc>
  <lastmod>2023-06-28T13:12:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/First-Wave-BioPharma-Strengthens-Intellectual-Property-Estate</loc>
  <lastmod>2023-06-28T13:12:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/AIM-ImmunoTech-Announces-Authorizations-from-Competent-Authority-and-Ethics-Board-in-the-Netherlands-to-Begin-a-Phase-1b2-Study-Evaluating-Ampligen</loc>
  <lastmod>2023-06-28T13:11:35+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/AIM-ImmunoTech-Announces-Authorizations-from-Competent-Authority-and-Ethics-Board-in-the-Netherlands-to-Begin-a-Phase-1b2-Study-Evaluating-Ampligen</loc>
  <lastmod>2023-06-28T13:11:35+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Immutep-Completes-A80-Million-Capital-Raise</loc>
  <lastmod>2023-06-28T13:10:59+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Immutep-Completes-A80-Million-Capital-Raise</loc>
  <lastmod>2023-06-28T13:10:59+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Orchard-Therapeutics-Announces-Second-Closing-of-Strategic-Financing-Resulting-in-34-Million-of-Additional-Capital</loc>
  <lastmod>2023-06-27T08:45:55+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Orchard-Therapeutics-Announces-Second-Closing-of-Strategic-Financing-Resulting-in-34-Million-of-Additional-Capital</loc>
  <lastmod>2023-06-27T08:45:55+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/TransCode-Therapeutics-Announces-Publication-of-New-Data-Supporting-the-Use-of-TTX-MC138-for-the-Treatment-of-Metastatic-Breast-Cancer-1</loc>
  <lastmod>2023-06-26T11:08:33+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/TransCode-Therapeutics-Announces-Publication-of-New-Data-Supporting-the-Use-of-TTX-MC138-for-the-Treatment-of-Metastatic-Breast-Cancer-1</loc>
  <lastmod>2023-06-26T11:08:33+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Invivyd-Announces-Positive-Initial-Data-from-Ongoing-Phase-1-Clinical-Trial-of-VYD222-a-Monoclonal-Antibody-Candidate-in-Development-for-the-Prevention-of-Symptomatic-COVID-19-in-Immunocompromised-People-1</loc>
  <lastmod>2023-06-26T11:07:51+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Invivyd-Announces-Positive-Initial-Data-from-Ongoing-Phase-1-Clinical-Trial-of-VYD222-a-Monoclonal-Antibody-Candidate-in-Development-for-the-Prevention-of-Symptomatic-COVID-19-in-Immunocompromised-People-1</loc>
  <lastmod>2023-06-26T11:07:51+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/NurExone-Reports-Positive-Results-for-Intranasal-ExoPTEN-in-Spinal-Cord-Regeneration-and-Reinnervation-in-Rats</loc>
  <lastmod>2023-06-26T11:07:06+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/NurExone-Reports-Positive-Results-for-Intranasal-ExoPTEN-in-Spinal-Cord-Regeneration-and-Reinnervation-in-Rats</loc>
  <lastmod>2023-06-26T11:07:06+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Parthenon-Therapeutics-Announces-Publication-in-Journal-for-ImmunoTherapy-of-Cancer-on-the-Role-of-PRTH-101-Inhibiting-DDR1-in-Immune-Excluded-Tumors-1</loc>
  <lastmod>2023-06-26T11:06:27+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Parthenon-Therapeutics-Announces-Publication-in-Journal-for-ImmunoTherapy-of-Cancer-on-the-Role-of-PRTH-101-Inhibiting-DDR1-in-Immune-Excluded-Tumors-1</loc>
  <lastmod>2023-06-26T11:06:27+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Expanding-ALS-Trial-Eligibility-Could-Benefit-Patients-Therapeutic-Progress-1</loc>
  <lastmod>2023-06-26T11:05:50+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Expanding-ALS-Trial-Eligibility-Could-Benefit-Patients-Therapeutic-Progress-1</loc>
  <lastmod>2023-06-26T11:05:50+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Molecure-Files-an-Investigational-New-Drug-IND-Application-for-Lead-Clinical-Candidate-OATD-01-with-US-FDA-Ahead-of-a-Planned-Phase-2-Pulmonary-Sarcoidosis-Study</loc>
  <lastmod>2023-06-26T11:05:11+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Molecure-Files-an-Investigational-New-Drug-IND-Application-for-Lead-Clinical-Candidate-OATD-01-with-US-FDA-Ahead-of-a-Planned-Phase-2-Pulmonary-Sarcoidosis-Study</loc>
  <lastmod>2023-06-26T11:05:11+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/RevolKa-Ltd-Announces-Milestone-Achievement-in-Collaborative-Research-with-Sumitomo-Pharma-Co-Ltd</loc>
  <lastmod>2023-06-26T11:04:27+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/RevolKa-Ltd-Announces-Milestone-Achievement-in-Collaborative-Research-with-Sumitomo-Pharma-Co-Ltd</loc>
  <lastmod>2023-06-26T11:04:27+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/AbbVie-Secures-Positive-CHMP-Opinion-for-Atogepant-for-the-Preventive-Treatment-of-Adults-with-Migraine</loc>
  <lastmod>2023-06-26T11:03:49+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/AbbVie-Secures-Positive-CHMP-Opinion-for-Atogepant-for-the-Preventive-Treatment-of-Adults-with-Migraine</loc>
  <lastmod>2023-06-26T11:03:49+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/HiFiBiO-Therapeutics-Doses-First-Patient-with-HFB200301-in-Combination-with-Tislelizumab-for-Advanced-Solid-Tumors</loc>
  <lastmod>2023-06-26T11:03:08+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/HiFiBiO-Therapeutics-Doses-First-Patient-with-HFB200301-in-Combination-with-Tislelizumab-for-Advanced-Solid-Tumors</loc>
  <lastmod>2023-06-26T11:03:08+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Amylyx-Pharmaceuticals-Receives-CHMP-Negative-Opinion-on-its-Conditional-Marketing-Authorisation-Application-for-AMX0035-for-the-Treatment-of-ALS-in-the-European-Union</loc>
  <lastmod>2023-06-26T11:01:16+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Amylyx-Pharmaceuticals-Receives-CHMP-Negative-Opinion-on-its-Conditional-Marketing-Authorisation-Application-for-AMX0035-for-the-Treatment-of-ALS-in-the-European-Union</loc>
  <lastmod>2023-06-26T11:01:16+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Jubilant-Radiopharma-and-Evergreen-Theragnostics-Announce-Collaboration-for-the-Sale-and-Distribution-of-Neuroendocrine-Tumor-Diagnostic-OCTEVY%E2%84%A2-Pending-FDA-Approval-in-2H-2023</loc>
  <lastmod>2023-06-26T11:00:36+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Jubilant-Radiopharma-and-Evergreen-Theragnostics-Announce-Collaboration-for-the-Sale-and-Distribution-of-Neuroendocrine-Tumor-Diagnostic-OCTEVY%E2%84%A2-Pending-FDA-Approval-in-2H-2023</loc>
  <lastmod>2023-06-26T11:00:36+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Q-BioMed-Inc-Provides-Update-to-Shareholders-June-23-2023</loc>
  <lastmod>2023-06-26T10:59:56+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Q-BioMed-Inc-Provides-Update-to-Shareholders-June-23-2023</loc>
  <lastmod>2023-06-26T10:59:56+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Ocean-Biomedical-Extends-Patent-Rights-for-Breakthrough-Idiopathic-Pulmonary-Fibrosis-Discovery-To-Europe</loc>
  <lastmod>2023-06-26T10:59:20+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Ocean-Biomedical-Extends-Patent-Rights-for-Breakthrough-Idiopathic-Pulmonary-Fibrosis-Discovery-To-Europe</loc>
  <lastmod>2023-06-26T10:59:20+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Jubilant%E2%80%99s-Precision-Medicines-Offer-Safety-Therapeutic-Advantages-in-Cancer-Immunology-2</loc>
  <lastmod>2023-06-26T10:58:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Jubilant%E2%80%99s-Precision-Medicines-Offer-Safety-Therapeutic-Advantages-in-Cancer-Immunology-2</loc>
  <lastmod>2023-06-26T10:58:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Seelos-Therapeutics-Closes-Enrollment-of-Study-for-Intranasal-Ketamine-Treatment-for-Acute-Suicidal-Ideation-and-Behavior-in-Major-Depressive-Disorder-Patients</loc>
  <lastmod>2023-06-23T08:32:55+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Seelos-Therapeutics-Closes-Enrollment-of-Study-for-Intranasal-Ketamine-Treatment-for-Acute-Suicidal-Ideation-and-Behavior-in-Major-Depressive-Disorder-Patients</loc>
  <lastmod>2023-06-23T08:32:55+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Jasper-Therapeutics-Announces-First-Patient-Dosed-in-a-Phase-1-Trial-of-Briquilimab-in-Lower-Risk-Myelodysplastic-Syndrome</loc>
  <lastmod>2023-06-23T08:32:18+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Jasper-Therapeutics-Announces-First-Patient-Dosed-in-a-Phase-1-Trial-of-Briquilimab-in-Lower-Risk-Myelodysplastic-Syndrome</loc>
  <lastmod>2023-06-23T08:32:18+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Vaxxinity-Announces-UB-312-Successfully-Met-Primary-Objectives-of-Phase-1-Clinical-Trial-in-Parkinson%E2%80%99s-Disease</loc>
  <lastmod>2023-06-23T08:31:41+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Vaxxinity-Announces-UB-312-Successfully-Met-Primary-Objectives-of-Phase-1-Clinical-Trial-in-Parkinson%E2%80%99s-Disease</loc>
  <lastmod>2023-06-23T08:31:41+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Tvardi-Therapeutics-Announces-First-Patients-Dosed-in-its-Phase-2-Liver-Cancer-Trial-Using-TTI-101-a-Novel-STAT3-Inhibitor</loc>
  <lastmod>2023-06-23T08:31:03+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Tvardi-Therapeutics-Announces-First-Patients-Dosed-in-its-Phase-2-Liver-Cancer-Trial-Using-TTI-101-a-Novel-STAT3-Inhibitor</loc>
  <lastmod>2023-06-23T08:31:03+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Cartesian-Therapeutics-Announces-Landmark-Study-in-The-Lancet-Neurology-of-First-Successful-Clinical-Trial-of-RNA-Cell-Therapy-in-Autoimmunity</loc>
  <lastmod>2023-06-23T08:30:59+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Cartesian-Therapeutics-Announces-Landmark-Study-in-The-Lancet-Neurology-of-First-Successful-Clinical-Trial-of-RNA-Cell-Therapy-in-Autoimmunity</loc>
  <lastmod>2023-06-23T08:30:59+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Propanc-Biopharma-Provides-Shareholder-Update-and-Plans-to-Enter-Clinical-Development-Stage-with-Lead-Cancer-Treatment-Candidate</loc>
  <lastmod>2023-07-08T12:02:26+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Propanc-Biopharma-Provides-Shareholder-Update-and-Plans-to-Enter-Clinical-Development-Stage-with-Lead-Cancer-Treatment-Candidate</loc>
  <lastmod>2023-07-08T12:02:26+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Compugen-Doses-First-Patient-in-Triple-Immunotherapy-Combination-COM701-COM902-and-Pembrolizumab-Platinum-Resistant-Ovarian-Cancer-Proof-of-Concept-Study</loc>
  <lastmod>2023-06-23T08:29:18+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Compugen-Doses-First-Patient-in-Triple-Immunotherapy-Combination-COM701-COM902-and-Pembrolizumab-Platinum-Resistant-Ovarian-Cancer-Proof-of-Concept-Study</loc>
  <lastmod>2023-06-23T08:29:18+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Oncolytics-Biotechs-Pelareorep-Selected-for-Inclusion-in-Precision-Promise-Pivotal-Phase-3-Platform-Trial</loc>
  <lastmod>2023-06-23T08:28:46+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Oncolytics-Biotechs-Pelareorep-Selected-for-Inclusion-in-Precision-Promise-Pivotal-Phase-3-Platform-Trial</loc>
  <lastmod>2023-06-23T08:28:46+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/PolyPid-Announces-Recruitment-of-First-Patient-in-Revised-SHIELD-II-Phase-3-Trial-Evaluating-D-PLEX%E2%82%81%E2%82%80%E2%82%80-for-Prevention-of-Abdominal-Colorectal-Surgical-Site-Infections</loc>
  <lastmod>2023-06-23T08:28:12+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/PolyPid-Announces-Recruitment-of-First-Patient-in-Revised-SHIELD-II-Phase-3-Trial-Evaluating-D-PLEX%E2%82%81%E2%82%80%E2%82%80-for-Prevention-of-Abdominal-Colorectal-Surgical-Site-Infections</loc>
  <lastmod>2023-06-23T08:28:12+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/TransCode-Therapeutics-Announces-Publication-of-New-Data-Supporting-the-Use-of-TTX-MC138-for-the-Treatment-of-Metastatic-Breast-Cancer</loc>
  <lastmod>2023-06-23T08:26:52+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/TransCode-Therapeutics-Announces-Publication-of-New-Data-Supporting-the-Use-of-TTX-MC138-for-the-Treatment-of-Metastatic-Breast-Cancer</loc>
  <lastmod>2023-06-23T08:26:52+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Invivyd-Announces-Positive-Initial-Data-from-Ongoing-Phase-1-Clinical-Trial-of-VYD222-a-Monoclonal-Antibody-Candidate-in-Development-for-the-Prevention-of-Symptomatic-COVID-19-in-Immunocompromised-People</loc>
  <lastmod>2023-06-23T08:26:19+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Invivyd-Announces-Positive-Initial-Data-from-Ongoing-Phase-1-Clinical-Trial-of-VYD222-a-Monoclonal-Antibody-Candidate-in-Development-for-the-Prevention-of-Symptomatic-COVID-19-in-Immunocompromised-People</loc>
  <lastmod>2023-06-23T08:26:19+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Parthenon-Therapeutics-Announces-Publication-in-Journal-for-ImmunoTherapy-of-Cancer-on-the-Role-of-PRTH-101-Inhibiting-DDR1-in-Immune-Excluded-Tumors</loc>
  <lastmod>2023-06-23T08:25:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Parthenon-Therapeutics-Announces-Publication-in-Journal-for-ImmunoTherapy-of-Cancer-on-the-Role-of-PRTH-101-Inhibiting-DDR1-in-Immune-Excluded-Tumors</loc>
  <lastmod>2023-06-23T08:25:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Expanding-ALS-Trial-Eligibility-Could-Benefit-Patients-Therapeutic-Progress</loc>
  <lastmod>2023-06-23T08:25:05+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Expanding-ALS-Trial-Eligibility-Could-Benefit-Patients-Therapeutic-Progress</loc>
  <lastmod>2023-06-23T08:25:05+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Jubilants-Precision-Medicines-Offer-Safety-Therapeutic-Advantages-in-Cancer-Immunology</loc>
  <lastmod>2023-06-23T08:24:32+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Jubilants-Precision-Medicines-Offer-Safety-Therapeutic-Advantages-in-Cancer-Immunology</loc>
  <lastmod>2023-06-23T08:24:32+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/GSK-Shares-Positive-Data-for-AREXVY-its-Respiratory-Syncytial-Virus-RSV-Older-Adult-Vaccine-Indicating-Protection-Over-Two-RSV-Seasons</loc>
  <lastmod>2023-06-22T10:56:03+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/GSK-Shares-Positive-Data-for-AREXVY-its-Respiratory-Syncytial-Virus-RSV-Older-Adult-Vaccine-Indicating-Protection-Over-Two-RSV-Seasons</loc>
  <lastmod>2023-06-22T10:56:03+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Mozart-Therapeutics-Presents-Preclinical-Data-for-MTX-101-a-Novel-CD8-Treg-Network-Modulator-for-Treatment-of-Autoimmune-Disease-at-FOCIS-2023-Annual-Meeting</loc>
  <lastmod>2023-06-22T10:27:10+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Mozart-Therapeutics-Presents-Preclinical-Data-for-MTX-101-a-Novel-CD8-Treg-Network-Modulator-for-Treatment-of-Autoimmune-Disease-at-FOCIS-2023-Annual-Meeting</loc>
  <lastmod>2023-06-22T10:27:10+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Virion-Therapeutics-Presents-VRON-0200-Preclinical-Data-Showing-Direct-Correlations-Between-Intrahepatic-CD8-T-cells-and-Hepatitis-B-Virus-Declines-HBV-at-EASL-2023</loc>
  <lastmod>2023-06-22T10:26:30+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Virion-Therapeutics-Presents-VRON-0200-Preclinical-Data-Showing-Direct-Correlations-Between-Intrahepatic-CD8-T-cells-and-Hepatitis-B-Virus-Declines-HBV-at-EASL-2023</loc>
  <lastmod>2023-06-22T10:26:30+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Rani-Therapeutics%E2%80%99-Oral-Delivery-of-PTH-for-Osteoporosis-Wins-Presidential-Poster-Competition-at-ENDO-2023-Annual-Conference</loc>
  <lastmod>2023-06-22T10:25:51+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Rani-Therapeutics%E2%80%99-Oral-Delivery-of-PTH-for-Osteoporosis-Wins-Presidential-Poster-Competition-at-ENDO-2023-Annual-Conference</loc>
  <lastmod>2023-06-22T10:25:51+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Vistagen-Announces-Results-of-Successful-US-Phase-1-Study-of-Itruvone-PH10-Enabling-US-Phase-2B-Development-for-Treatment-of-Major-Depressive-Disorder</loc>
  <lastmod>2023-06-22T10:25:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Vistagen-Announces-Results-of-Successful-US-Phase-1-Study-of-Itruvone-PH10-Enabling-US-Phase-2B-Development-for-Treatment-of-Major-Depressive-Disorder</loc>
  <lastmod>2023-06-22T10:25:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Blue-Earth-Diagnostics-and-PETNET-Solutions-Inc-Announce-US-Commercial-Availability-of-POSLUMA%C2%AE-for-PET-Imaging-of-Prostate-Cancer</loc>
  <lastmod>2023-06-22T10:24:35+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Blue-Earth-Diagnostics-and-PETNET-Solutions-Inc-Announce-US-Commercial-Availability-of-POSLUMA%C2%AE-for-PET-Imaging-of-Prostate-Cancer</loc>
  <lastmod>2023-06-22T10:24:35+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Cardio-Diagnostics-Holdings-Launches-PrecisionCHD%E2%84%A2-for-Nationwide-Detection-of-Coronary-Heart-Disease</loc>
  <lastmod>2023-06-22T10:23:57+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Cardio-Diagnostics-Holdings-Launches-PrecisionCHD%E2%84%A2-for-Nationwide-Detection-of-Coronary-Heart-Disease</loc>
  <lastmod>2023-06-22T10:23:57+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/CorMedix-Inc-Announces-FDA-Acceptance-of-Resubmission-of-New-Drug-Application-for-DefenCath-June-21-2023</loc>
  <lastmod>2023-06-22T10:23:19+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/CorMedix-Inc-Announces-FDA-Acceptance-of-Resubmission-of-New-Drug-Application-for-DefenCath-June-21-2023</loc>
  <lastmod>2023-06-22T10:23:19+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/SAB-Biotherapeutics-Presents-Positive-IND-Enabling-GLP-Toxicology-Study-for-SAB-142-a-Novel-Immunotherapeutic-for-Type-1-Diabetes-at-FOCIS-2023</loc>
  <lastmod>2023-06-22T10:22:44+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/SAB-Biotherapeutics-Presents-Positive-IND-Enabling-GLP-Toxicology-Study-for-SAB-142-a-Novel-Immunotherapeutic-for-Type-1-Diabetes-at-FOCIS-2023</loc>
  <lastmod>2023-06-22T10:22:44+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Amarin-Announces-Vascepa%C2%AE-Icosapent-Ethyl-Approved-to-Reduce-Cardiovascular-Ri</loc>
  <lastmod>2023-07-22T16:59:35+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Amarin-Announces-Vascepa%C2%AE-Icosapent-Ethyl-Approved-to-Reduce-Cardiovascular-Ri</loc>
  <lastmod>2023-07-22T16:59:35+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/AISA-Pharma-Announces-Start-of-Phase-2b-Profervia%C2%AE-Study-for-Raynauds-Phenomenon-in-Systemic-Sclerosis-SSc</loc>
  <lastmod>2023-06-22T10:21:31+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/AISA-Pharma-Announces-Start-of-Phase-2b-Profervia%C2%AE-Study-for-Raynauds-Phenomenon-in-Systemic-Sclerosis-SSc</loc>
  <lastmod>2023-06-22T10:21:31+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Eloxx-Pharmaceuticals-Highlights-Recent-Alport-Syndrome-Natural-History-Data-Presented-at-60th-ERA-Congress</loc>
  <lastmod>2023-06-22T10:20:52+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Eloxx-Pharmaceuticals-Highlights-Recent-Alport-Syndrome-Natural-History-Data-Presented-at-60th-ERA-Congress</loc>
  <lastmod>2023-06-22T10:20:52+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Biomerica-Receives-Notice-of-Patent-Allowance-in-China-for-a-Potential-Innovative-Technology</loc>
  <lastmod>2023-06-22T10:20:16+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Biomerica-Receives-Notice-of-Patent-Allowance-in-China-for-a-Potential-Innovative-Technology</loc>
  <lastmod>2023-06-22T10:20:16+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Dar%C3%A9-Bioscience-Announces-Publication-in-Menopause-for-Phase-12-Clinical-Trial-of-DARE-HRT1-for-Treatment-of-Vasomotor-Symptoms-due-to-Menopause</loc>
  <lastmod>2023-06-22T10:19:39+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Dar%C3%A9-Bioscience-Announces-Publication-in-Menopause-for-Phase-12-Clinical-Trial-of-DARE-HRT1-for-Treatment-of-Vasomotor-Symptoms-due-to-Menopause</loc>
  <lastmod>2023-06-22T10:19:39+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Jubilant%E2%80%99s-Precision-Medicines-Offer-Safety-Therapeutic-Advantages-in-Cancer-Immunology-1</loc>
  <lastmod>2023-06-22T10:18:58+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Jubilant%E2%80%99s-Precision-Medicines-Offer-Safety-Therapeutic-Advantages-in-Cancer-Immunology-1</loc>
  <lastmod>2023-06-22T10:18:58+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Sirnaomics-Advances-STP705-for-Squamous-Cell-Carcinoma-In-Situ-into-Late-Stage-Clinical-Development</loc>
  <lastmod>2023-06-20T08:37:16+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Sirnaomics-Advances-STP705-for-Squamous-Cell-Carcinoma-In-Situ-into-Late-Stage-Clinical-Development</loc>
  <lastmod>2023-06-20T08:37:16+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Department-of-Health-Abu-Dhabi-M42-and-AbbVie-Enter-Strategic-Partnership-for-Personalized-Medicine-and-Genomics</loc>
  <lastmod>2023-06-20T08:36:22+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Department-of-Health-Abu-Dhabi-M42-and-AbbVie-Enter-Strategic-Partnership-for-Personalized-Medicine-and-Genomics</loc>
  <lastmod>2023-06-20T08:36:22+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Avanos-Medical-Inc-Announces-Agreement-to-Acquire-Diros-Technology-Inc</loc>
  <lastmod>2023-06-20T08:35:41+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Avanos-Medical-Inc-Announces-Agreement-to-Acquire-Diros-Technology-Inc</loc>
  <lastmod>2023-06-20T08:35:41+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/FemAid-Announces-Completion-of-Prototyping-and-Patent-Application-for-Revolutionary-Non-Surgical-Non-Drug-Female-Incontinence-Device</loc>
  <lastmod>2023-06-20T08:35:01+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/FemAid-Announces-Completion-of-Prototyping-and-Patent-Application-for-Revolutionary-Non-Surgical-Non-Drug-Female-Incontinence-Device</loc>
  <lastmod>2023-06-20T08:35:01+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Auxilius-Pharma-Raises-Seed-Round-of-1-Million-and-Commences-its-Clinical-Program</loc>
  <lastmod>2023-06-20T08:34:23+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Auxilius-Pharma-Raises-Seed-Round-of-1-Million-and-Commences-its-Clinical-Program</loc>
  <lastmod>2023-06-20T08:34:23+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Ascelia-Pharma-Presents-Orviglance-Hepatic-Impairment-Data-and-Hosts-QA-with-Liver-Imaging-Experts-at-the-2023-ESGAR-Annual-Meeting</loc>
  <lastmod>2023-06-20T08:33:28+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Ascelia-Pharma-Presents-Orviglance-Hepatic-Impairment-Data-and-Hosts-QA-with-Liver-Imaging-Experts-at-the-2023-ESGAR-Annual-Meeting</loc>
  <lastmod>2023-06-20T08:33:28+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/First-Patient-Dosed-in-Phase-II-STARBURST-Study-of-TLX250-CDx-Exploring-Indication-Expansion</loc>
  <lastmod>2023-06-20T08:32:48+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/First-Patient-Dosed-in-Phase-II-STARBURST-Study-of-TLX250-CDx-Exploring-Indication-Expansion</loc>
  <lastmod>2023-06-20T08:32:48+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Opinion-Manage-a-Team-Here%E2%80%99s-How-to-Keep-Your-Top-Performers</loc>
  <lastmod>2023-06-20T08:32:05+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Opinion-Manage-a-Team-Here%E2%80%99s-How-to-Keep-Your-Top-Performers</loc>
  <lastmod>2023-06-20T08:32:05+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Public-Private-Alliance-Chooses-Eight-Rare-Diseases-for-Focused-Gene-Therapy-Development</loc>
  <lastmod>2023-06-20T08:31:26+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Public-Private-Alliance-Chooses-Eight-Rare-Diseases-for-Focused-Gene-Therapy-Development</loc>
  <lastmod>2023-06-20T08:31:26+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/FDA-Action-Alert-Argenx-Aldeyra-Intercept-and-Sarepta</loc>
  <lastmod>2023-06-20T08:30:33+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/FDA-Action-Alert-Argenx-Aldeyra-Intercept-and-Sarepta</loc>
  <lastmod>2023-06-20T08:30:33+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Jubilant%E2%80%99s-Precision-Medicines-Offer-Safety-Therapeutic-Advantages-in-Cancer-Immunology</loc>
  <lastmod>2023-06-20T08:29:48+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Jubilant%E2%80%99s-Precision-Medicines-Offer-Safety-Therapeutic-Advantages-in-Cancer-Immunology</loc>
  <lastmod>2023-06-20T08:29:48+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Merck-Finalizes-108B-Prometheus-Buy</loc>
  <lastmod>2023-06-20T08:28:49+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Merck-Finalizes-108B-Prometheus-Buy</loc>
  <lastmod>2023-06-20T08:28:49+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Lilly%E2%80%99s-Migraine-Drug-Emgality-Fails-to-Outperform-Pfizer%E2%80%99s-Nurtec</loc>
  <lastmod>2023-06-20T08:28:04+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Lilly%E2%80%99s-Migraine-Drug-Emgality-Fails-to-Outperform-Pfizer%E2%80%99s-Nurtec</loc>
  <lastmod>2023-06-20T08:28:04+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/BioSenic-Puts-Fracture-Cell-Therapy-Program-on-Hold-After-Mid-Stage-Failure</loc>
  <lastmod>2023-06-20T08:27:25+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/BioSenic-Puts-Fracture-Cell-Therapy-Program-on-Hold-After-Mid-Stage-Failure</loc>
  <lastmod>2023-06-20T08:27:25+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/BMS-Follows-Merck%E2%80%99s-Lead-Sues-Government-Over-Drug-Pricing-Negotiation</loc>
  <lastmod>2023-06-20T08:26:44+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/BMS-Follows-Merck%E2%80%99s-Lead-Sues-Government-Over-Drug-Pricing-Negotiation</loc>
  <lastmod>2023-06-20T08:26:44+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Clearmind-Medicine-and-SciSparc-to-Conduct-Study-Evaluating-Combination-Treatment-for-Obesity-and-Metabolic-Syndrome</loc>
  <lastmod>2023-06-19T01:33:59+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Clearmind-Medicine-and-SciSparc-to-Conduct-Study-Evaluating-Combination-Treatment-for-Obesity-and-Metabolic-Syndrome</loc>
  <lastmod>2023-06-19T01:33:59+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Incannex-Appoints-Principal-Investigators-for-IHL-42X-Phase-23-Clinical-Trial</loc>
  <lastmod>2023-06-19T01:33:09+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Incannex-Appoints-Principal-Investigators-for-IHL-42X-Phase-23-Clinical-Trial</loc>
  <lastmod>2023-06-19T01:33:09+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Sona-Nanotech-Selects-Minnetronix-to-Engineer-Its-Next-Generation-Targeted-Hypothermia-Cancer-Therapy-Light-Device</loc>
  <lastmod>2023-06-19T01:32:30+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Sona-Nanotech-Selects-Minnetronix-to-Engineer-Its-Next-Generation-Targeted-Hypothermia-Cancer-Therapy-Light-Device</loc>
  <lastmod>2023-06-19T01:32:30+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Merck-Completes-Acquisition-of-Prometheus-Biosciences-Inc</loc>
  <lastmod>2023-06-19T01:31:51+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Merck-Completes-Acquisition-of-Prometheus-Biosciences-Inc</loc>
  <lastmod>2023-06-19T01:31:51+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Aldeyras-Phase-III-Data-Show-Positive-Results-for-Eye-Treatment</loc>
  <lastmod>2023-06-19T01:31:11+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Aldeyras-Phase-III-Data-Show-Positive-Results-for-Eye-Treatment</loc>
  <lastmod>2023-06-19T01:31:11+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Clene-Reports-Promising-NfL-Biomarker-Data-for-ALS-Hopeful</loc>
  <lastmod>2023-06-19T01:30:31+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Clene-Reports-Promising-NfL-Biomarker-Data-for-ALS-Hopeful</loc>
  <lastmod>2023-06-19T01:30:31+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Roche-and-AbbVie-to-Compete-with-New-Bispecific-Antibodies-for-Lymphoma-Market-Share</loc>
  <lastmod>2023-06-19T01:29:51+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Roche-and-AbbVie-to-Compete-with-New-Bispecific-Antibodies-for-Lymphoma-Market-Share</loc>
  <lastmod>2023-06-19T01:29:51+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/After-Adcomm%E2%80%99s-Vaccine-Recommendation-Can-Novavax-Make-a-Covid-Comeback</loc>
  <lastmod>2023-06-19T01:29:07+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/After-Adcomm%E2%80%99s-Vaccine-Recommendation-Can-Novavax-Make-a-Covid-Comeback</loc>
  <lastmod>2023-06-19T01:29:07+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Coherus-Expands-Portfolio-with-65M-Acquisition-of-Surface-Oncology</loc>
  <lastmod>2023-06-19T01:28:29+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Coherus-Expands-Portfolio-with-65M-Acquisition-of-Surface-Oncology</loc>
  <lastmod>2023-06-19T01:28:29+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Merck-Eyes-Keytruda-Indication-Update-with-Phase-III-Gastric-Cancer-Data</loc>
  <lastmod>2023-06-19T01:28:01+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Merck-Eyes-Keytruda-Indication-Update-with-Phase-III-Gastric-Cancer-Data</loc>
  <lastmod>2023-06-19T01:28:01+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Leqembi%E2%80%99s-Rollout-Could-Face-Challenges-as-FDA-Advisory-Committee-Gives-Unanimous-Blessing-for-Full-Approval</loc>
  <lastmod>2023-06-19T01:27:21+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Leqembi%E2%80%99s-Rollout-Could-Face-Challenges-as-FDA-Advisory-Committee-Gives-Unanimous-Blessing-for-Full-Approval</loc>
  <lastmod>2023-06-19T01:27:21+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Molecular-Templates-Announces-Debt-Payoff-and-Restructuring</loc>
  <lastmod>2023-06-19T01:26:40+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Molecular-Templates-Announces-Debt-Payoff-and-Restructuring</loc>
  <lastmod>2023-06-19T01:26:40+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Hoth-Therapeutics-Announces-IRB-Approval-for-FDA-Cleared-First-In-Human-Clinical-Trial-of-HT-001-at-Second-Clinical-Site</loc>
  <lastmod>2023-06-15T09:25:57+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Hoth-Therapeutics-Announces-IRB-Approval-for-FDA-Cleared-First-In-Human-Clinical-Trial-of-HT-001-at-Second-Clinical-Site</loc>
  <lastmod>2023-06-15T09:25:57+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Amneal-Pharmaceuticals-Receives-FDA-Approval-for-PEMRYDI-RTU-a-Ready-to-Use-Oncology-Injectable</loc>
  <lastmod>2023-06-15T09:02:29+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Amneal-Pharmaceuticals-Receives-FDA-Approval-for-PEMRYDI-RTU-a-Ready-to-Use-Oncology-Injectable</loc>
  <lastmod>2023-06-15T09:02:29+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/PDS-Biotechnology-Announces-Achievement-of-Efficacy-Threshold-in-Stage-2-of-the-VERSATILE-002-Trial-Evaluating-PDS0101-and-KEYTRUDA%C2%AE-in-Head-and-Neck-Cancer</loc>
  <lastmod>2023-06-15T09:01:48+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/PDS-Biotechnology-Announces-Achievement-of-Efficacy-Threshold-in-Stage-2-of-the-VERSATILE-002-Trial-Evaluating-PDS0101-and-KEYTRUDA%C2%AE-in-Head-and-Neck-Cancer</loc>
  <lastmod>2023-06-15T09:01:48+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/MindRank-Announces-First-in-Human-Phase-1-Study-of-MDR-001-in-China</loc>
  <lastmod>2023-06-15T09:00:58+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/MindRank-Announces-First-in-Human-Phase-1-Study-of-MDR-001-in-China</loc>
  <lastmod>2023-06-15T09:00:58+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/IO-Biotech-Announces-Achievement-of-Significant-Phase-3-Clinical-Trial-Recruitment-Milestone</loc>
  <lastmod>2023-06-15T09:00:15+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/IO-Biotech-Announces-Achievement-of-Significant-Phase-3-Clinical-Trial-Recruitment-Milestone</loc>
  <lastmod>2023-06-15T09:00:15+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Baby%E2%80%99s-%E2%80%98Nagging-Cough%E2%80%99-Leads-to-Shock-Diagnosis-of-Rare-Incurable-and-Deadly-Disease</loc>
  <lastmod>2023-06-15T08:59:36+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Baby%E2%80%99s-%E2%80%98Nagging-Cough%E2%80%99-Leads-to-Shock-Diagnosis-of-Rare-Incurable-and-Deadly-Disease</loc>
  <lastmod>2023-06-15T08:59:36+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Vetter-a-Globally-Operating-CDMO-Publishes-Annual-Sustainability-Report</loc>
  <lastmod>2023-06-15T08:58:54+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Vetter-a-Globally-Operating-CDMO-Publishes-Annual-Sustainability-Report</loc>
  <lastmod>2023-06-15T08:58:54+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Vyriad-Announces-Expansion-of-T-Cell-Lymphoma-Trial-at-Mayo-Clinic</loc>
  <lastmod>2023-06-15T08:58:10+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Vyriad-Announces-Expansion-of-T-Cell-Lymphoma-Trial-at-Mayo-Clinic</loc>
  <lastmod>2023-06-15T08:58:10+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Employee-Engagement-Continues-to-Decline-Amid-Talent-War-Gallup-Study-Finds</loc>
  <lastmod>2023-06-15T08:59:09+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Employee-Engagement-Continues-to-Decline-Amid-Talent-War-Gallup-Study-Finds</loc>
  <lastmod>2023-06-15T08:59:09+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Biopharma-Confronts-a-Rising-Tide-of-Ransomware-Attacks</loc>
  <lastmod>2023-06-15T08:55:32+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Biopharma-Confronts-a-Rising-Tide-of-Ransomware-Attacks</loc>
  <lastmod>2023-06-15T08:55:32+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Merck-Gets-FDA-Fast-Track-for-Efinopegdutide-Previews-NASH-Data-Versus-Novo%E2%80%99s-Semaglutide</loc>
  <lastmod>2023-06-15T08:54:50+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Merck-Gets-FDA-Fast-Track-for-Efinopegdutide-Previews-NASH-Data-Versus-Novo%E2%80%99s-Semaglutide</loc>
  <lastmod>2023-06-15T08:54:50+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Biogen-Teams-with-NeuroSense-to-Explore-ALS-Neurofilament-Biomarker</loc>
  <lastmod>2023-06-15T08:54:11+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Biogen-Teams-with-NeuroSense-to-Explore-ALS-Neurofilament-Biomarker</loc>
  <lastmod>2023-06-15T08:54:11+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Kura-Hopes-to-Raise-100M-in-Public-Offering-on-Heels-of-Clinical-Data</loc>
  <lastmod>2023-06-15T08:54:55+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Kura-Hopes-to-Raise-100M-in-Public-Offering-on-Heels-of-Clinical-Data</loc>
  <lastmod>2023-06-15T08:54:55+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/2seventy-bios-CAR-T-Trial-Halted-After-Pediatric-Death</loc>
  <lastmod>2023-06-15T08:52:54+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/2seventy-bios-CAR-T-Trial-Halted-After-Pediatric-Death</loc>
  <lastmod>2023-06-15T08:52:54+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Self-Sampling-Using-Colli-Pee%C2%AE-Device-for-HPV-Screening-Is-Both-Cost-Effective-and-Could-Improve-Patient-Access-Study-Concludes</loc>
  <lastmod>2023-06-14T08:54:32+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Self-Sampling-Using-Colli-Pee%C2%AE-Device-for-HPV-Screening-Is-Both-Cost-Effective-and-Could-Improve-Patient-Access-Study-Concludes</loc>
  <lastmod>2023-06-14T08:54:32+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Heligenics-Unveils-A-First-Of-Its-Kind-Precision-Prescription-Test-For-Breast-Cancer-Therapeutics</loc>
  <lastmod>2023-06-14T08:53:51+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Heligenics-Unveils-A-First-Of-Its-Kind-Precision-Prescription-Test-For-Breast-Cancer-Therapeutics</loc>
  <lastmod>2023-06-14T08:53:51+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/US-FDA-Approves-Bylvay%C2%AE-for-Patients-Living-with-Cholestatic-Pruritus-Due-to-Alagille-Syndrome</loc>
  <lastmod>2023-06-14T08:53:14+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/US-FDA-Approves-Bylvay%C2%AE-for-Patients-Living-with-Cholestatic-Pruritus-Due-to-Alagille-Syndrome</loc>
  <lastmod>2023-06-14T08:53:14+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Brand-Institute-Partners-on-Brand-Name-Development-for-FDA-Approved-Eye-Drops-for-the-Treatment-of-the-Signs-and-Symptoms-of-Dry-Eye-Disease</loc>
  <lastmod>2023-06-14T08:52:29+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Brand-Institute-Partners-on-Brand-Name-Development-for-FDA-Approved-Eye-Drops-for-the-Treatment-of-the-Signs-and-Symptoms-of-Dry-Eye-Disease</loc>
  <lastmod>2023-06-14T08:52:29+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/OliX-Pharmaceuticals-Begins-Phase-1-Clinical-Study-of-RNAi-Therapeutic-for-Androgenic-Alopecia</loc>
  <lastmod>2023-06-14T08:51:51+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/OliX-Pharmaceuticals-Begins-Phase-1-Clinical-Study-of-RNAi-Therapeutic-for-Androgenic-Alopecia</loc>
  <lastmod>2023-06-14T08:51:51+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Vistagen-Announces-European-Patent-Office-Intention-to-Grant-New-PH80-Nasal-Spray-Patent-for-the-Treatment-of-Migraine</loc>
  <lastmod>2023-06-14T08:51:10+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Vistagen-Announces-European-Patent-Office-Intention-to-Grant-New-PH80-Nasal-Spray-Patent-for-the-Treatment-of-Migraine</loc>
  <lastmod>2023-06-14T08:51:10+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Kalderos-2023-Annual-Report-Highlights-Costs-of-Systemic-Challenges-in-Drug-Discount-Programs-and-Their-Impact-on-Drug-Manufacturers-Covered-Entities-Payers-and-Patients</loc>
  <lastmod>2023-06-14T08:50:34+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Kalderos-2023-Annual-Report-Highlights-Costs-of-Systemic-Challenges-in-Drug-Discount-Programs-and-Their-Impact-on-Drug-Manufacturers-Covered-Entities-Payers-and-Patients</loc>
  <lastmod>2023-06-14T08:50:34+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/70-of-Major-Pharmaceutical-Companies-and-CROs-Surveyed-Have-Adopted-Digital-Pathology</loc>
  <lastmod>2023-06-14T08:49:52+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/70-of-Major-Pharmaceutical-Companies-and-CROs-Surveyed-Have-Adopted-Digital-Pathology</loc>
  <lastmod>2023-06-14T08:49:52+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/The-Truth-About-Unlimited-PTO</loc>
  <lastmod>2023-06-14T08:49:17+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/The-Truth-About-Unlimited-PTO</loc>
  <lastmod>2023-06-14T08:49:17+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Catalent-Finally-Reports-Earnings-Despite-Losses-Revenue-Beat-Projections</loc>
  <lastmod>2023-06-14T08:48:37+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Catalent-Finally-Reports-Earnings-Despite-Losses-Revenue-Beat-Projections</loc>
  <lastmod>2023-06-14T08:48:37+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Valneva-Reports-Strong-Phase-III-Chikungunya-Vaccine-Data-After-Merck%E2%80%99s-Exit-from-Race</loc>
  <lastmod>2023-06-14T08:48:02+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Valneva-Reports-Strong-Phase-III-Chikungunya-Vaccine-Data-After-Merck%E2%80%99s-Exit-from-Race</loc>
  <lastmod>2023-06-14T08:48:02+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Seagen-Touts-Adcetris-Early-Stage-Lymphoma-Data-with-93-Complete-Remission</loc>
  <lastmod>2023-06-14T08:47:25+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Seagen-Touts-Adcetris-Early-Stage-Lymphoma-Data-with-93-Complete-Remission</loc>
  <lastmod>2023-06-14T08:47:25+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/JJ-settles-Stelara-issue-with-Teva-Alvotech</loc>
  <lastmod>2023-06-14T08:46:50+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/JJ-settles-Stelara-issue-with-Teva-Alvotech</loc>
  <lastmod>2023-06-14T08:46:50+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Biogen-Makes-Changes-to-Board-of-Directors-Ahead-of-Annual-Shareholder-Meeting</loc>
  <lastmod>2023-06-14T08:46:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Biogen-Makes-Changes-to-Board-of-Directors-Ahead-of-Annual-Shareholder-Meeting</loc>
  <lastmod>2023-06-14T08:46:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Turnstone-Biologics-Files-for-86M-IPO-Amid-Financial-Difficulties</loc>
  <lastmod>2023-06-14T08:45:37+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Turnstone-Biologics-Files-for-86M-IPO-Amid-Financial-Difficulties</loc>
  <lastmod>2023-06-14T08:45:37+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Endo-Launches-PREVDUO%E2%84%A2-the-First-and-Only-FDA-Approved-Neostigmine-Glycopyrrolate-Combination-Pre-Filled-Syringe</loc>
  <lastmod>2023-06-13T11:34:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Endo-Launches-PREVDUO%E2%84%A2-the-First-and-Only-FDA-Approved-Neostigmine-Glycopyrrolate-Combination-Pre-Filled-Syringe</loc>
  <lastmod>2023-06-13T11:34:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Eccogene-Raises-CNY-180-Million-in-Series-B-Equity-Financing-for-Treatments-of-Metabolic-Diseases</loc>
  <lastmod>2023-06-13T11:34:01+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Eccogene-Raises-CNY-180-Million-in-Series-B-Equity-Financing-for-Treatments-of-Metabolic-Diseases</loc>
  <lastmod>2023-06-13T11:34:01+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Vaccitech-Doses-First-Patient-in-PCA001-a-Prostate-Cancer-Phase-12-Clinical-Trial-of-VTP-850-Immunotherapeutic-Candidate-in-Men-with-Rising-PSA-after-Definitive-Local-Therapy</loc>
  <lastmod>2023-06-13T11:33:25+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Vaccitech-Doses-First-Patient-in-PCA001-a-Prostate-Cancer-Phase-12-Clinical-Trial-of-VTP-850-Immunotherapeutic-Candidate-in-Men-with-Rising-PSA-after-Definitive-Local-Therapy</loc>
  <lastmod>2023-06-13T11:33:25+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/InnoCare-Presents-Data-on-Orelabrutinib-at-European-Hematology-Association-Congress</loc>
  <lastmod>2023-06-13T11:32:39+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/InnoCare-Presents-Data-on-Orelabrutinib-at-European-Hematology-Association-Congress</loc>
  <lastmod>2023-06-13T11:32:39+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/China-Medical-Systems-Diazepam-Nasal-Spray-Approved-for-Marketing-in-China</loc>
  <lastmod>2023-06-13T11:31:50+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/China-Medical-Systems-Diazepam-Nasal-Spray-Approved-for-Marketing-in-China</loc>
  <lastmod>2023-06-13T11:31:50+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Parthenon-Therapeutics-Announces-Publication-in-Journal-for-ImmunoTherapy-of-Cancer-on-the-Role-of-Immune-Exclusion-in-Cancer</loc>
  <lastmod>2023-06-13T11:29:47+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Parthenon-Therapeutics-Announces-Publication-in-Journal-for-ImmunoTherapy-of-Cancer-on-the-Role-of-Immune-Exclusion-in-Cancer</loc>
  <lastmod>2023-06-13T11:29:47+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Ferring-Pharmaceuticals-Receives-US-FDA-Approval-for-Manufacturing-Scale-up-Process-of-Gene-Therapy-ADSTILADRIN%C2%AE</loc>
  <lastmod>2023-06-13T11:29:16+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Ferring-Pharmaceuticals-Receives-US-FDA-Approval-for-Manufacturing-Scale-up-Process-of-Gene-Therapy-ADSTILADRIN%C2%AE</loc>
  <lastmod>2023-06-13T11:29:16+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Ironwood-Pharmaceuticals-Announces-FDA-Approval-of-New-Indication-for-LINZESS%C2%AE-for-Pediatric-Patients-with-Functional-Constipation</loc>
  <lastmod>2023-06-13T11:28:36+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Ironwood-Pharmaceuticals-Announces-FDA-Approval-of-New-Indication-for-LINZESS%C2%AE-for-Pediatric-Patients-with-Functional-Constipation</loc>
  <lastmod>2023-06-13T11:28:36+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/BIOTRONIK-Announces-First-Implant-of-New-Implantable-Cardiac-Monitor-with-Artificial-Intelligence</loc>
  <lastmod>2023-06-13T11:28:01+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/BIOTRONIK-Announces-First-Implant-of-New-Implantable-Cardiac-Monitor-with-Artificial-Intelligence</loc>
  <lastmod>2023-06-13T11:28:01+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/FDA-Braces-for-Looming-Boom-in-Cell-and-Gene-Therapy-Submissions</loc>
  <lastmod>2023-06-13T11:26:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/FDA-Braces-for-Looming-Boom-in-Cell-and-Gene-Therapy-Submissions</loc>
  <lastmod>2023-06-13T11:26:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/FDA-Action-Alert-BMS-GSK-Ironwood-IpsenAlbireo</loc>
  <lastmod>2023-06-13T11:25:38+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/FDA-Action-Alert-BMS-GSK-Ironwood-IpsenAlbireo</loc>
  <lastmod>2023-06-13T11:25:38+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Chamber-of-Commerce-Files-IRA-Lawsuit-Against-Biden-Administration-Follows-Merck</loc>
  <lastmod>2023-06-13T11:24:59+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Chamber-of-Commerce-Files-IRA-Lawsuit-Against-Biden-Administration-Follows-Merck</loc>
  <lastmod>2023-06-13T11:24:59+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Illumina-CEO-DeSouza-Steps-Down-Amid-Activist-Attack-Anti-Trust-Battle</loc>
  <lastmod>2023-06-13T11:24:19+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Illumina-CEO-DeSouza-Steps-Down-Amid-Activist-Attack-Anti-Trust-Battle</loc>
  <lastmod>2023-06-13T11:24:19+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Pharma-Companies-Pharmacies-Agree-to-Pay-19B-in-Opioid-Settlement</loc>
  <lastmod>2023-06-13T11:23:40+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Pharma-Companies-Pharmacies-Agree-to-Pay-19B-in-Opioid-Settlement</loc>
  <lastmod>2023-06-13T11:23:40+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Novartis-to-Acquire-Kidney-Player-Chinook-Therapeutics-for-32-Billion</loc>
  <lastmod>2023-06-13T11:23:05+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Novartis-to-Acquire-Kidney-Player-Chinook-Therapeutics-for-32-Billion</loc>
  <lastmod>2023-06-13T11:23:05+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Gene-Editing-Race-Between-Editas-and-Vertex-CRISPR-Heats-Up-1</loc>
  <lastmod>2023-06-12T09:17:15+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Gene-Editing-Race-Between-Editas-and-Vertex-CRISPR-Heats-Up-1</loc>
  <lastmod>2023-06-12T09:17:15+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/FDA-Adcomm-Unanimously-Backs-Full-Approval-of-Eisai-Biogen%E2%80%99s-Leqembi-2</loc>
  <lastmod>2023-06-12T09:16:40+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/FDA-Adcomm-Unanimously-Backs-Full-Approval-of-Eisai-Biogen%E2%80%99s-Leqembi-2</loc>
  <lastmod>2023-06-12T09:16:40+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/AstraZeneca-and-Quell-to-Develop-Cell-Therapies-in-2B-Deal-for-Type-1-Diabetes-and-IBD-1</loc>
  <lastmod>2023-06-12T09:16:11+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/AstraZeneca-and-Quell-to-Develop-Cell-Therapies-in-2B-Deal-for-Type-1-Diabetes-and-IBD-1</loc>
  <lastmod>2023-06-12T09:16:11+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Protagonist-Therapeutics-Plans-a-Follow-on-Two-Year-Extension-Study-to-Enable-Further-Evaluation-of-the-Long-Term-Effects-of-Rusfertide</loc>
  <lastmod>2023-06-11T03:01:55+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Protagonist-Therapeutics-Plans-a-Follow-on-Two-Year-Extension-Study-to-Enable-Further-Evaluation-of-the-Long-Term-Effects-of-Rusfertide</loc>
  <lastmod>2023-06-11T03:01:55+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Astellas-Submits-New-Drug-Application-for-Zolbetuximab-in-Japan</loc>
  <lastmod>2023-06-11T03:01:19+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Astellas-Submits-New-Drug-Application-for-Zolbetuximab-in-Japan</loc>
  <lastmod>2023-06-11T03:01:19+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Kymera-Therapeutics-Announces-Updated-Clinical-Data-from-the-Phase-1-Trials-of-STAT3-Degrader-KT-333-and-IRAKIMiD-Degrader-KT-413</loc>
  <lastmod>2023-06-11T03:00:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Kymera-Therapeutics-Announces-Updated-Clinical-Data-from-the-Phase-1-Trials-of-STAT3-Degrader-KT-333-and-IRAKIMiD-Degrader-KT-413</loc>
  <lastmod>2023-06-11T03:00:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/NRx-Pharmaceuticals-Announces-Closing-of-628-Million-Registered-Direct-Offering</loc>
  <lastmod>2023-06-11T03:00:04+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/NRx-Pharmaceuticals-Announces-Closing-of-628-Million-Registered-Direct-Offering</loc>
  <lastmod>2023-06-11T03:00:04+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Dar%C3%A9-Bioscience-Announces-Publication-of-Phase-12-Pharmacokinetic-Safety-and-Pharmacodynamic-Data-for-DARE-VVA1</loc>
  <lastmod>2023-06-11T02:59:28+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Dar%C3%A9-Bioscience-Announces-Publication-of-Phase-12-Pharmacokinetic-Safety-and-Pharmacodynamic-Data-for-DARE-VVA1</loc>
  <lastmod>2023-06-11T02:59:28+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Milla-Pharmaceuticals-and-Alter-Pharma-Group-Receive-FDA-Approval-for-Dexmedetomidine-Hydrochloride-Injection</loc>
  <lastmod>2023-06-11T02:58:52+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Milla-Pharmaceuticals-and-Alter-Pharma-Group-Receive-FDA-Approval-for-Dexmedetomidine-Hydrochloride-Injection</loc>
  <lastmod>2023-06-11T02:58:52+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Inspire-Medical-Systems-Inc-Announces-FDA-Approval-for-Apnea-Hypopnea-Index-Indication-Expansion-and-Increased-Body-Mass-Index-Labeling-1</loc>
  <lastmod>2023-06-11T02:58:17+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Inspire-Medical-Systems-Inc-Announces-FDA-Approval-for-Apnea-Hypopnea-Index-Indication-Expansion-and-Increased-Body-Mass-Index-Labeling-1</loc>
  <lastmod>2023-06-11T02:58:17+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Sumitomo-Pharma-Oncology-Inc-Presents-Updated-Preliminary-Data-from-Phase-12-Clinical-Study-Evaluating-Investigational-Agent-TP-3654-in-Patients-with-Myelofibrosis-at-European-Hematology-Association-2023-Hybrid-Congress-1</loc>
  <lastmod>2023-06-11T02:57:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Sumitomo-Pharma-Oncology-Inc-Presents-Updated-Preliminary-Data-from-Phase-12-Clinical-Study-Evaluating-Investigational-Agent-TP-3654-in-Patients-with-Myelofibrosis-at-European-Hematology-Association-2023-Hybrid-Congress-1</loc>
  <lastmod>2023-06-11T02:57:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/ACROBiosystems-Aneuro-Partners-with-Diagnostic-Biochips-to-Accelerate-Neuroscience-Drug-Discovery-1</loc>
  <lastmod>2023-06-11T02:57:01+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/ACROBiosystems-Aneuro-Partners-with-Diagnostic-Biochips-to-Accelerate-Neuroscience-Drug-Discovery-1</loc>
  <lastmod>2023-06-11T02:57:01+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Stem-Cell-Therapy-Market-Size-to-Reach-Around-USD-3141-BN-by-2030-1</loc>
  <lastmod>2023-06-11T02:56:22+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Stem-Cell-Therapy-Market-Size-to-Reach-Around-USD-3141-BN-by-2030-1</loc>
  <lastmod>2023-06-11T02:56:22+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Biden-Administration-Imposes-Penalties-on-43-Drugs-Due-to-Price-Hikes-1</loc>
  <lastmod>2023-06-11T02:54:22+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Biden-Administration-Imposes-Penalties-on-43-Drugs-Due-to-Price-Hikes-1</loc>
  <lastmod>2023-06-11T02:54:22+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/AstraZeneca-and-Sanofis-Pediatric-RSV-Antibody-Receives-Unanimous-Backing-from-FDA-Panel-1</loc>
  <lastmod>2023-06-11T02:53:47+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/AstraZeneca-and-Sanofis-Pediatric-RSV-Antibody-Receives-Unanimous-Backing-from-FDA-Panel-1</loc>
  <lastmod>2023-06-11T02:53:47+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Gene-Editing-Race-Between-Editas-and-Vertex-CRISPR-Heats-Up</loc>
  <lastmod>2023-06-11T02:53:10+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Gene-Editing-Race-Between-Editas-and-Vertex-CRISPR-Heats-Up</loc>
  <lastmod>2023-06-11T02:53:10+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/FDA-Adcomm-Unanimously-Backs-Full-Approval-of-Eisai-Biogen%E2%80%99s-Leqembi-1</loc>
  <lastmod>2023-07-14T11:45:17+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/FDA-Adcomm-Unanimously-Backs-Full-Approval-of-Eisai-Biogen%E2%80%99s-Leqembi-1</loc>
  <lastmod>2023-07-14T11:45:17+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/AstraZeneca-and-Quell-to-Develop-Cell-Therapies-for-Type-1-Diabetes-and-IBD-in-2B-Deal</loc>
  <lastmod>2023-06-11T02:52:01+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/AstraZeneca-and-Quell-to-Develop-Cell-Therapies-for-Type-1-Diabetes-and-IBD-in-2B-Deal</loc>
  <lastmod>2023-06-11T02:52:01+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Milla-Pharmaceuticals-Inc-and-Alter-Pharma-Group-Receive-FDA-Approval-for-Dexmedetomidine-Hydrochloride-Injection</loc>
  <lastmod>2023-06-10T14:59:26+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Milla-Pharmaceuticals-Inc-and-Alter-Pharma-Group-Receive-FDA-Approval-for-Dexmedetomidine-Hydrochloride-Injection</loc>
  <lastmod>2023-06-10T14:59:26+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Inspire-Medical-Systems-Inc-Announces-FDA-Approval-for-Apnea-Hypopnea-Index-Indication-Expansion-and-Increased-Body-Mass-Index-Labeling</loc>
  <lastmod>2023-06-10T14:58:48+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Inspire-Medical-Systems-Inc-Announces-FDA-Approval-for-Apnea-Hypopnea-Index-Indication-Expansion-and-Increased-Body-Mass-Index-Labeling</loc>
  <lastmod>2023-06-10T14:58:48+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Sumitomo-Pharma-Oncology-Inc-Presents-Updated-Preliminary-Data-from-Phase-12-Clinical-Study-Evaluating-Investigational-Agent-TP-3654-in-Patients-with-Myelofibrosis-at-European-Hematology-Association-2023-Hybrid-Congress</loc>
  <lastmod>2023-06-10T14:58:14+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Sumitomo-Pharma-Oncology-Inc-Presents-Updated-Preliminary-Data-from-Phase-12-Clinical-Study-Evaluating-Investigational-Agent-TP-3654-in-Patients-with-Myelofibrosis-at-European-Hematology-Association-2023-Hybrid-Congress</loc>
  <lastmod>2023-06-10T14:58:14+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/ACROBiosystems-Aneuro-Partners-with-Diagnostic-Biochips-to-Accelerate-Neuroscience-Drug-Discovery</loc>
  <lastmod>2023-06-10T14:57:33+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/ACROBiosystems-Aneuro-Partners-with-Diagnostic-Biochips-to-Accelerate-Neuroscience-Drug-Discovery</loc>
  <lastmod>2023-06-10T14:57:33+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Stem-Cell-Therapy-Market-Size-to-Reach-Around-USD-3141-BN-by-2030</loc>
  <lastmod>2023-06-10T14:56:49+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Stem-Cell-Therapy-Market-Size-to-Reach-Around-USD-3141-BN-by-2030</loc>
  <lastmod>2023-06-10T14:56:49+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Biden-Administration-Imposes-Penalties-on-43-Drugs-Due-to-Price-Hikes</loc>
  <lastmod>2023-06-10T14:54:50+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Biden-Administration-Imposes-Penalties-on-43-Drugs-Due-to-Price-Hikes</loc>
  <lastmod>2023-06-10T14:54:50+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/AstraZeneca-and-Sanofis-Pediatric-RSV-Antibody-Receives-Unanimous-Backing-from-FDA-Panel</loc>
  <lastmod>2023-06-10T14:54:15+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/AstraZeneca-and-Sanofis-Pediatric-RSV-Antibody-Receives-Unanimous-Backing-from-FDA-Panel</loc>
  <lastmod>2023-06-10T14:54:15+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Editas-and-VertexCRISPR-in-Gene-Editing-Race-for-Sickle-Cell-Disease-and-Beta-Thalassemia-Treatments</loc>
  <lastmod>2023-06-10T14:53:40+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Editas-and-VertexCRISPR-in-Gene-Editing-Race-for-Sickle-Cell-Disease-and-Beta-Thalassemia-Treatments</loc>
  <lastmod>2023-06-10T14:53:40+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/FDA-Adcomm-Unanimously-Backs-Full-Approval-of-Eisai-Biogen%E2%80%99s-Leqembi</loc>
  <lastmod>2023-06-10T14:52:57+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/FDA-Adcomm-Unanimously-Backs-Full-Approval-of-Eisai-Biogen%E2%80%99s-Leqembi</loc>
  <lastmod>2023-06-10T14:52:57+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/AstraZeneca-and-Quell-to-Develop-Cell-Therapies-in-2B-Deal-for-Type-1-Diabetes-and-IBD</loc>
  <lastmod>2023-06-10T14:52:21+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/AstraZeneca-and-Quell-to-Develop-Cell-Therapies-in-2B-Deal-for-Type-1-Diabetes-and-IBD</loc>
  <lastmod>2023-06-10T14:52:21+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/China-Approves-the-Worlds-First-Vaccine-against-XBB-Descendent-Lineages-of-SARS-CoV-2-for-Emergency-Use</loc>
  <lastmod>2023-06-10T14:50:41+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/China-Approves-the-Worlds-First-Vaccine-against-XBB-Descendent-Lineages-of-SARS-CoV-2-for-Emergency-Use</loc>
  <lastmod>2023-06-10T14:50:41+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Shionogi-Enrolls-the-First-Participant-in-Japan-in-its-Global-Phase-3-Trial-of-Ensitrelvir-for-the-Prevention-of-Symptomatic-SARS-CoV-2-Infection</loc>
  <lastmod>2023-06-10T14:49:57+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Shionogi-Enrolls-the-First-Participant-in-Japan-in-its-Global-Phase-3-Trial-of-Ensitrelvir-for-the-Prevention-of-Symptomatic-SARS-CoV-2-Infection</loc>
  <lastmod>2023-06-10T14:49:57+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Elevation-Oncology-Announces-Pricing-of-50-Million-Public-Offering</loc>
  <lastmod>2023-06-10T14:49:19+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Elevation-Oncology-Announces-Pricing-of-50-Million-Public-Offering</loc>
  <lastmod>2023-06-10T14:49:19+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/TPG-and-AmerisourceBergen-Complete-Acquisition-of-OneOncology</loc>
  <lastmod>2023-06-10T14:48:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/TPG-and-AmerisourceBergen-Complete-Acquisition-of-OneOncology</loc>
  <lastmod>2023-06-10T14:48:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/andros-Announces-CEO-Transition</loc>
  <lastmod>2023-06-09T08:49:00+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/andros-Announces-CEO-Transition</loc>
  <lastmod>2023-06-09T08:49:00+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Enochian-BioSciences-Announces-that-its-Cancer-Platform-Remains-on-Track-for-Trials-in-Humans-Following-FDA-Review</loc>
  <lastmod>2023-06-09T08:48:27+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Enochian-BioSciences-Announces-that-its-Cancer-Platform-Remains-on-Track-for-Trials-in-Humans-Following-FDA-Review</loc>
  <lastmod>2023-06-09T08:48:27+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Medical-Technology-Associates-Acquires-Premier-Medical</loc>
  <lastmod>2023-06-09T08:47:45+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Medical-Technology-Associates-Acquires-Premier-Medical</loc>
  <lastmod>2023-06-09T08:47:45+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Femasys%E2%80%99-FemCath-Intrauterine-Catheter-Receives-Product-Approval-in-Canada</loc>
  <lastmod>2023-06-09T08:47:09+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Femasys%E2%80%99-FemCath-Intrauterine-Catheter-Receives-Product-Approval-in-Canada</loc>
  <lastmod>2023-06-09T08:47:09+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Indica-Labs-Launches-Comprehensive-Management-Service-for-HALO%C2%AE-Software-in-AWS-Cloud-Hosted-Environments</loc>
  <lastmod>2023-06-09T08:46:25+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Indica-Labs-Launches-Comprehensive-Management-Service-for-HALO%C2%AE-Software-in-AWS-Cloud-Hosted-Environments</loc>
  <lastmod>2023-06-09T08:46:25+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Roches-Cerebrospinal-Fluid-Assays-Approved-in-Canada-for-Alzheimers-Diagnosis</loc>
  <lastmod>2023-06-09T08:45:48+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Roches-Cerebrospinal-Fluid-Assays-Approved-in-Canada-for-Alzheimers-Diagnosis</loc>
  <lastmod>2023-06-09T08:45:48+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Avanos-Medical-Inc-Announces-Sale-of-Respiratory-Health-Business-to-SunMed-Group-Holdings-LLC</loc>
  <lastmod>2023-06-09T08:45:06+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Avanos-Medical-Inc-Announces-Sale-of-Respiratory-Health-Business-to-SunMed-Group-Holdings-LLC</loc>
  <lastmod>2023-06-09T08:45:06+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Iktos-and-Curreio-Announce-Collaboration-Agreement-in-New-Drug-Discovery</loc>
  <lastmod>2023-06-09T08:44:28+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Iktos-and-Curreio-Announce-Collaboration-Agreement-in-New-Drug-Discovery</loc>
  <lastmod>2023-06-09T08:44:28+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Columbus-Cincinnati-Indianapolis-Top-List-of-Emerging-Hubs-for-Researchers</loc>
  <lastmod>2023-06-09T08:43:51+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Columbus-Cincinnati-Indianapolis-Top-List-of-Emerging-Hubs-for-Researchers</loc>
  <lastmod>2023-06-09T08:43:51+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Bitterroot-Launches-with-145M-Series-A-to-Advance-Cardio-Immuno-Therapies</loc>
  <lastmod>2023-06-09T08:43:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Bitterroot-Launches-with-145M-Series-A-to-Advance-Cardio-Immuno-Therapies</loc>
  <lastmod>2023-06-09T08:43:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Upstream-Bio-Adds-Another-200M-for-Asthma-Allergy-Pipeline</loc>
  <lastmod>2023-06-09T08:42:34+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Upstream-Bio-Adds-Another-200M-for-Asthma-Allergy-Pipeline</loc>
  <lastmod>2023-06-09T08:42:34+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Lilly-Takeda-Face-Class-Action-Racketeering-Lawsuit-Over-Diabetes-Drug-Actos</loc>
  <lastmod>2023-06-09T08:41:51+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Lilly-Takeda-Face-Class-Action-Racketeering-Lawsuit-Over-Diabetes-Drug-Actos</loc>
  <lastmod>2023-06-09T08:41:51+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/FDA-Indicates-Potential-Full-Approval-for-Eisai-Biogen%E2%80%99s-Leqembi-Ahead-of-Adcomm-1</loc>
  <lastmod>2023-06-09T08:41:12+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/FDA-Indicates-Potential-Full-Approval-for-Eisai-Biogen%E2%80%99s-Leqembi-Ahead-of-Adcomm-1</loc>
  <lastmod>2023-06-09T08:41:12+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/ASCO-in-Review-Oncologists-See-Practice-Changing-Affirming-Data</loc>
  <lastmod>2023-06-09T08:40:29+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/ASCO-in-Review-Oncologists-See-Practice-Changing-Affirming-Data</loc>
  <lastmod>2023-06-09T08:40:29+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Astellas-Partners-with-Kate-Therapeutics-in-Gene-Therapy-After-Four-Patient-Deaths-in-Previous-Trials</loc>
  <lastmod>2023-06-09T08:39:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Astellas-Partners-with-Kate-Therapeutics-in-Gene-Therapy-After-Four-Patient-Deaths-in-Previous-Trials</loc>
  <lastmod>2023-06-09T08:39:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/FTC%E2%80%99s-Challenge-to-Amgen-Horizon-Merger-Sparks-Industry-Attention</loc>
  <lastmod>2023-06-08T15:45:07+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/FTC%E2%80%99s-Challenge-to-Amgen-Horizon-Merger-Sparks-Industry-Attention</loc>
  <lastmod>2023-06-08T15:45:07+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Moderna-Pfizer-Hit-with-New-COVID-Vaccine-Patent-Lawsuits</loc>
  <lastmod>2023-06-08T15:44:06+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Moderna-Pfizer-Hit-with-New-COVID-Vaccine-Patent-Lawsuits</loc>
  <lastmod>2023-06-08T15:44:06+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/FibroGen%E2%80%99s-Duchenne-Muscular-Dystrophy-Drug-Fails-Phase-III-Trial</loc>
  <lastmod>2023-06-08T15:42:27+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/FibroGen%E2%80%99s-Duchenne-Muscular-Dystrophy-Drug-Fails-Phase-III-Trial</loc>
  <lastmod>2023-06-08T15:42:27+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/FDA-Indicates-Potential-Full-Approval-for-Eisai-Biogen%E2%80%99s-Leqembi-Ahead-of-Adcomm</loc>
  <lastmod>2023-06-08T15:41:27+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/FDA-Indicates-Potential-Full-Approval-for-Eisai-Biogen%E2%80%99s-Leqembi-Ahead-of-Adcomm</loc>
  <lastmod>2023-06-08T15:41:27+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/NanOlogy-Presents-Clinical-Research-at-2023-DDW-and-ASCO-Involving-its-Large-Surface-Area-Microparticle-Investigational-Drugs</loc>
  <lastmod>2023-06-08T14:52:29+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/NanOlogy-Presents-Clinical-Research-at-2023-DDW-and-ASCO-Involving-its-Large-Surface-Area-Microparticle-Investigational-Drugs</loc>
  <lastmod>2023-06-08T14:52:29+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/BioInvent-Announces-Additional-Efficacy-Data-from-Intravenous-Part-of-Phase-12-Trial-with-BI-1206-in-Solid-Tumors</loc>
  <lastmod>2023-06-08T14:51:17+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/BioInvent-Announces-Additional-Efficacy-Data-from-Intravenous-Part-of-Phase-12-Trial-with-BI-1206-in-Solid-Tumors</loc>
  <lastmod>2023-06-08T14:51:17+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/LIXTE-Biotechnology-and-Spanish-Sarcoma-Group-Enroll-First-Patient-in-Phase-1b2-Trial-of-LB-100-for-Soft-Tissue-Sarcomas</loc>
  <lastmod>2023-06-08T14:52:32+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/LIXTE-Biotechnology-and-Spanish-Sarcoma-Group-Enroll-First-Patient-in-Phase-1b2-Trial-of-LB-100-for-Soft-Tissue-Sarcomas</loc>
  <lastmod>2023-06-08T14:52:32+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Inari-Medical-Launches-New-Products-for-Venous-Stent-Thrombosis-and-Thromboembolism</loc>
  <lastmod>2023-06-08T14:53:01+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Inari-Medical-Launches-New-Products-for-Venous-Stent-Thrombosis-and-Thromboembolism</loc>
  <lastmod>2023-06-08T14:53:01+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Vistagen-Announces-Positive-Results-from-Exploratory-Phase-2A-Study-of-PH80-in-Women-Diagnosed-with-Menopausal-Hot-Flashes</loc>
  <lastmod>2023-06-08T14:53:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Vistagen-Announces-Positive-Results-from-Exploratory-Phase-2A-Study-of-PH80-in-Women-Diagnosed-with-Menopausal-Hot-Flashes</loc>
  <lastmod>2023-06-08T14:53:13+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Capricor-Therapeutics-Announces-Follow-up-Type-B-Clinical-Meeting-with-the-FDA-for-CAP-1002-for-the-Treatment-of-Duchenne-Muscular-Dystrophy</loc>
  <lastmod>2023-06-08T14:53:44+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Capricor-Therapeutics-Announces-Follow-up-Type-B-Clinical-Meeting-with-the-FDA-for-CAP-1002-for-the-Treatment-of-Duchenne-Muscular-Dystrophy</loc>
  <lastmod>2023-06-08T14:53:44+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Baudax-Bio-Announces-Additional-Positive-Top-Line-Results-From-Phase-2-Randomized-Clinical-Trial-of-BX1000</loc>
  <lastmod>2023-06-08T14:53:53+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Baudax-Bio-Announces-Additional-Positive-Top-Line-Results-From-Phase-2-Randomized-Clinical-Trial-of-BX1000</loc>
  <lastmod>2023-06-08T14:53:53+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Study-Biosimilars-%E2%80%98Fulfilling-Their-Promise%E2%80%99-of-Lowering-Biologic-Prices</loc>
  <lastmod>2023-06-08T14:54:05+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Study-Biosimilars-%E2%80%98Fulfilling-Their-Promise%E2%80%99-of-Lowering-Biologic-Prices</loc>
  <lastmod>2023-06-08T14:54:05+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/%EC%9E%84%EC%83%81%EC%9D%98%ED%95%99%EC%9E%90-%EB%B0%8F-%EC%95%BD%EB%A6%AC%ED%95%99%EC%9E%90%EB%A5%BC-%EC%9C%84%ED%95%9C-%EB%8D%B0%EC%9D%B4%ED%84%B0%EB%B2%A0%EC%9D%B4%EC%8A%A4-%EA%B4%80%EB%A6%AC-%EC%8B%9C%EC%8A%A4%ED%85%9C%EC%9D%98-%EC%A4%91%EC%9A%94%EC%84%B1</loc>
  <lastmod>2023-06-06T16:05:23+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/%EC%9E%84%EC%83%81%EC%9D%98%ED%95%99%EC%9E%90-%EB%B0%8F-%EC%95%BD%EB%A6%AC%ED%95%99%EC%9E%90%EB%A5%BC-%EC%9C%84%ED%95%9C-%EB%8D%B0%EC%9D%B4%ED%84%B0%EB%B2%A0%EC%9D%B4%EC%8A%A4-%EA%B4%80%EB%A6%AC-%EC%8B%9C%EC%8A%A4%ED%85%9C%EC%9D%98-%EC%A4%91%EC%9A%94%EC%84%B1</loc>
  <lastmod>2023-06-06T16:05:23+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/%EA%B2%BD%EA%B5%AC%EC%9A%A9-%ED%95%AD%EC%95%94%EC%A0%9C-%EC%8B%9C%EC%9E%A5%EC%9D%98-%ED%98%84%EC%9E%AC-%EC%83%81%ED%83%9C-%EB%B0%8F-%EC%A0%84%EB%A7%9D</loc>
  <lastmod>2023-06-06T15:57:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/%EA%B2%BD%EA%B5%AC%EC%9A%A9-%ED%95%AD%EC%95%94%EC%A0%9C-%EC%8B%9C%EC%9E%A5%EC%9D%98-%ED%98%84%EC%9E%AC-%EC%83%81%ED%83%9C-%EB%B0%8F-%EC%A0%84%EB%A7%9D</loc>
  <lastmod>2023-06-06T15:57:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/%ED%99%94%EC%9D%B4%EC%9E%90%EC%9D%98-%ED%98%88%EC%9A%B0%EB%B3%91-%EC%B9%98%EB%A3%8C%EC%A0%9C-%EB%A7%88%EB%A5%B4%EC%8A%A4%ED%83%80%EC%8B%9C%EB%A7%99-%EC%9E%84%EC%83%81-3%EC%83%81%EC%97%90%EC%84%9C-%EC%97%B0%EA%B0%84%EC%B6%9C%ED%98%88%EB%A5%A0-35-%EA%B0%90%EC%86%8C-%ED%99%95%EC%9D%B8</loc>
  <lastmod>2023-06-01T14:11:30+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/%ED%99%94%EC%9D%B4%EC%9E%90%EC%9D%98-%ED%98%88%EC%9A%B0%EB%B3%91-%EC%B9%98%EB%A3%8C%EC%A0%9C-%EB%A7%88%EB%A5%B4%EC%8A%A4%ED%83%80%EC%8B%9C%EB%A7%99-%EC%9E%84%EC%83%81-3%EC%83%81%EC%97%90%EC%84%9C-%EC%97%B0%EA%B0%84%EC%B6%9C%ED%98%88%EB%A5%A0-35-%EA%B0%90%EC%86%8C-%ED%99%95%EC%9D%B8</loc>
  <lastmod>2023-06-01T14:11:30+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/%EB%B2%A0%EB%84%A4%EB%B3%BC%EB%9F%B0%ED%8A%B8AI-%EC%9D%B8%EB%A0%A5%EA%B0%90%EC%B6%95-%EB%B0%8F-%EC%95%BD%EB%AC%BC-%EA%B0%9C%EB%B0%9C-%EC%A4%91%EB%8B%A8</loc>
  <lastmod>2023-05-31T12:45:55+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/%EB%B2%A0%EB%84%A4%EB%B3%BC%EB%9F%B0%ED%8A%B8AI-%EC%9D%B8%EB%A0%A5%EA%B0%90%EC%B6%95-%EB%B0%8F-%EC%95%BD%EB%AC%BC-%EA%B0%9C%EB%B0%9C-%EC%A4%91%EB%8B%A8</loc>
  <lastmod>2023-05-31T12:45:55+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/%EC%B7%8C%EC%9E%A5%EC%95%94-%EC%A1%B0%EA%B8%B0-%EC%A7%84%EB%8B%A8%EC%97%90-%EB%8C%80%ED%95%9C-%EC%83%88%EB%A1%9C%EC%9A%B4-%EC%A7%84%EB%8B%A8-%EB%8F%84%EA%B5%AC</loc>
  <lastmod>2023-05-30T03:16:15+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/%EC%B7%8C%EC%9E%A5%EC%95%94-%EC%A1%B0%EA%B8%B0-%EC%A7%84%EB%8B%A8%EC%97%90-%EB%8C%80%ED%95%9C-%EC%83%88%EB%A1%9C%EC%9A%B4-%EC%A7%84%EB%8B%A8-%EB%8F%84%EA%B5%AC</loc>
  <lastmod>2023-05-30T03:16:15+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/%EC%83%9D%EB%AC%BC%ED%95%99%EC%A0%81-%EC%97%AD%ED%95%99%EC%9D%98-%EC%83%88%EB%A1%9C%EC%9A%B4-%EC%B7%8C%EC%9E%A5-%EB%B3%91%EB%B3%80-%EA%B2%80%EC%B6%9C-%EA%B8%B0%EC%88%A0</loc>
  <lastmod>2023-05-30T03:13:08+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/%EC%83%9D%EB%AC%BC%ED%95%99%EC%A0%81-%EC%97%AD%ED%95%99%EC%9D%98-%EC%83%88%EB%A1%9C%EC%9A%B4-%EC%B7%8C%EC%9E%A5-%EB%B3%91%EB%B3%80-%EA%B2%80%EC%B6%9C-%EA%B8%B0%EC%88%A0</loc>
  <lastmod>2023-05-30T03:13:08+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/IgA%EC%9D%98-%EB%AF%B8%EC%83%9D%EB%AC%BC%EA%B3%BC%EC%9D%98-%EC%83%81%ED%98%B8%EC%9E%91%EC%9A%A9-%EC%A1%B0%EC%A0%95</loc>
  <lastmod>2023-05-30T03:01:28+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/IgA%EC%9D%98-%EB%AF%B8%EC%83%9D%EB%AC%BC%EA%B3%BC%EC%9D%98-%EC%83%81%ED%98%B8%EC%9E%91%EC%9A%A9-%EC%A1%B0%EC%A0%95</loc>
  <lastmod>2023-05-30T03:01:28+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/%ED%8C%8C%ED%82%A8%EC%8A%A8%EB%B3%91-%EC%B9%98%EB%A3%8C%EC%A0%9C-%EA%B0%9C%EB%B0%9C-%ED%98%91%EC%95%BD-%ED%95%9C%EC%98%AC%EB%B0%94%EC%9D%B4%EC%98%A4%ED%8C%8C%EB%A7%88%EC%99%80-%EB%8C%80%EC%9B%85%EC%A0%9C%EC%95%BD%EC%9D%B4-%EB%89%B4%EB%A1%A0-%ED%8C%8C%EB%A7%88%EC%8A%88%ED%8B%B0%EC%BB%AC%EA%B3%BC-%EC%86%90%EC%9E%A1%EB%8B%A4</loc>
  <lastmod>2023-05-26T10:46:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/%ED%8C%8C%ED%82%A8%EC%8A%A8%EB%B3%91-%EC%B9%98%EB%A3%8C%EC%A0%9C-%EA%B0%9C%EB%B0%9C-%ED%98%91%EC%95%BD-%ED%95%9C%EC%98%AC%EB%B0%94%EC%9D%B4%EC%98%A4%ED%8C%8C%EB%A7%88%EC%99%80-%EB%8C%80%EC%9B%85%EC%A0%9C%EC%95%BD%EC%9D%B4-%EB%89%B4%EB%A1%A0-%ED%8C%8C%EB%A7%88%EC%8A%88%ED%8B%B0%EC%BB%AC%EA%B3%BC-%EC%86%90%EC%9E%A1%EB%8B%A4</loc>
  <lastmod>2023-05-26T10:46:43+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/%EB%A3%A8%EA%B2%8C%EB%A6%AD%EB%B3%91%EA%B3%BC-%EC%A0%84%EB%91%90%EC%B8%A1%EB%91%90%EC%97%BD%EC%B9%98%EB%A7%A4-%EC%B9%98%EB%A3%8C-%EA%B0%9C%EB%B0%9C-%EC%9B%A8%EC%9D%B4%EB%B8%8C-%EB%9D%BC%EC%9D%B4%ED%94%84%EC%82%AC%EC%9D%B4%EC%96%B8%EC%8A%A4%EA%B0%80-%EC%8B%A4%ED%8C%A8%EB%A5%BC-%EC%9D%B8%EC%A0%95%ED%95%98%EB%8B%A4</loc>
  <lastmod>2023-05-26T10:46:55+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/%EB%A3%A8%EA%B2%8C%EB%A6%AD%EB%B3%91%EA%B3%BC-%EC%A0%84%EB%91%90%EC%B8%A1%EB%91%90%EC%97%BD%EC%B9%98%EB%A7%A4-%EC%B9%98%EB%A3%8C-%EA%B0%9C%EB%B0%9C-%EC%9B%A8%EC%9D%B4%EB%B8%8C-%EB%9D%BC%EC%9D%B4%ED%94%84%EC%82%AC%EC%9D%B4%EC%96%B8%EC%8A%A4%EA%B0%80-%EC%8B%A4%ED%8C%A8%EB%A5%BC-%EC%9D%B8%EC%A0%95%ED%95%98%EB%8B%A4</loc>
  <lastmod>2023-05-26T10:46:55+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/%ED%8A%B8%EB%A6%AC%EC%98%A4%EC%96%B4-120%EC%96%B5%EC%9B%90%EC%9D%98-%EC%8B%9C%EB%A6%AC%EC%A6%88-A-%ED%88%AC%EC%9E%90%EB%A5%BC-%ED%86%B5%ED%95%B4-ADC-%ED%95%9C%EA%B3%84%EB%A5%BC-%EA%B7%B9%EB%B3%B5%ED%95%98%EB%8A%94-%EA%B8%B0%EC%88%A0-%EA%B0%9C%EB%B0%9C%EC%97%90-%EC%A7%91%EC%A4%91</loc>
  <lastmod>2023-05-24T14:38:20+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/%ED%8A%B8%EB%A6%AC%EC%98%A4%EC%96%B4-120%EC%96%B5%EC%9B%90%EC%9D%98-%EC%8B%9C%EB%A6%AC%EC%A6%88-A-%ED%88%AC%EC%9E%90%EB%A5%BC-%ED%86%B5%ED%95%B4-ADC-%ED%95%9C%EA%B3%84%EB%A5%BC-%EA%B7%B9%EB%B3%B5%ED%95%98%EB%8A%94-%EA%B8%B0%EC%88%A0-%EA%B0%9C%EB%B0%9C%EC%97%90-%EC%A7%91%EC%A4%91</loc>
  <lastmod>2023-05-24T14:38:20+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/%EC%95%84%EC%9D%B4%EC%96%B8%EC%9A%B0%EB%93%9C-10%EC%96%B5%EB%8B%AC%EB%9F%AC%EC%97%90-%EB%B2%A1%ED%8B%B0%EB%B8%8C%EB%B0%94%EC%9D%B4%EC%98%A4-%EC%9D%B8%EC%88%98-%E2%80%93-%EC%9E%A5%EB%B6%80%EC%A0%84-%EB%8F%99%EB%B0%98-%EB%8B%A8%EC%9E%A5%EC%A6%9D%ED%9B%84%EA%B5%B0-%EC%9E%84%EC%83%813%EC%83%81-%EC%95%BD%EB%AC%BC-%EC%95%84%ED%94%84%EB%9D%BC%EA%B8%80%EB%A3%A8%ED%83%80%EC%9D%B4%EB%93%9C-%EC%B6%94%EA%B0%80</loc>
  <lastmod>2023-05-24T13:36:35+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/%EC%95%84%EC%9D%B4%EC%96%B8%EC%9A%B0%EB%93%9C-10%EC%96%B5%EB%8B%AC%EB%9F%AC%EC%97%90-%EB%B2%A1%ED%8B%B0%EB%B8%8C%EB%B0%94%EC%9D%B4%EC%98%A4-%EC%9D%B8%EC%88%98-%E2%80%93-%EC%9E%A5%EB%B6%80%EC%A0%84-%EB%8F%99%EB%B0%98-%EB%8B%A8%EC%9E%A5%EC%A6%9D%ED%9B%84%EA%B5%B0-%EC%9E%84%EC%83%813%EC%83%81-%EC%95%BD%EB%AC%BC-%EC%95%84%ED%94%84%EB%9D%BC%EA%B8%80%EB%A3%A8%ED%83%80%EC%9D%B4%EB%93%9C-%EC%B6%94%EA%B0%80</loc>
  <lastmod>2023-05-24T13:36:35+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/Anixa-Biosciences-%EC%B0%A8%EC%84%B8%EB%8C%80-%EC%B9%98%EB%A3%8C%EB%B2%95%EC%9C%BC%EB%A1%9C-%EB%82%9C%EC%86%8C%EC%95%94-%EC%B9%98%EB%A3%8C%EC%9D%98-%EC%83%88%EB%A1%9C%EC%9A%B4-%EB%B0%A9%ED%96%A5</loc>
  <lastmod>2024-02-26T16:19:46+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/Anixa-Biosciences-%EC%B0%A8%EC%84%B8%EB%8C%80-%EC%B9%98%EB%A3%8C%EB%B2%95%EC%9C%BC%EB%A1%9C-%EB%82%9C%EC%86%8C%EC%95%94-%EC%B9%98%EB%A3%8C%EC%9D%98-%EC%83%88%EB%A1%9C%EC%9A%B4-%EB%B0%A9%ED%96%A5</loc>
  <lastmod>2024-02-26T16:19:46+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/3%EC%83%81-%EA%B2%B0%EA%B3%BC-%EB%93%80%ED%94%BC%EC%A0%A0%ED%8A%B8%EB%A5%BC-COPD%EC%97%90-%EB%8C%80%ED%95%9C-%EC%B2%AB-%EB%B2%88%EC%A7%B8-%EC%9E%A0%EC%9E%AC%EC%A0%81-%EC%83%9D%EB%AC%BC%ED%95%99%EC%A0%81-%EC%8A%B9%EC%9D%B8%EC%9C%BC%EB%A1%9C-%EC%84%A0%EC%A0%95</loc>
  <lastmod>2024-02-26T16:19:09+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/3%EC%83%81-%EA%B2%B0%EA%B3%BC-%EB%93%80%ED%94%BC%EC%A0%A0%ED%8A%B8%EB%A5%BC-COPD%EC%97%90-%EB%8C%80%ED%95%9C-%EC%B2%AB-%EB%B2%88%EC%A7%B8-%EC%9E%A0%EC%9E%AC%EC%A0%81-%EC%83%9D%EB%AC%BC%ED%95%99%EC%A0%81-%EC%8A%B9%EC%9D%B8%EC%9C%BC%EB%A1%9C-%EC%84%A0%EC%A0%95</loc>
  <lastmod>2024-02-26T16:19:09+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/DevOps%EB%9E%80-%EB%AC%B4%EC%97%87%EC%9D%B4%EB%A9%B0-%EC%99%9C-%EC%A4%91%EC%9A%94%ED%95%9C%EA%B0%80%EC%9A%94</loc>
  <lastmod>2023-05-23T02:00:06+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/DevOps%EB%9E%80-%EB%AC%B4%EC%97%87%EC%9D%B4%EB%A9%B0-%EC%99%9C-%EC%A4%91%EC%9A%94%ED%95%9C%EA%B0%80%EC%9A%94</loc>
  <lastmod>2023-05-23T02:00:06+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/entry/GLP-1-%EC%88%98%EC%9A%A9%EC%B2%B4-%EC%9E%91%EC%9A%A9%EC%A0%9C-%ED%98%84%EC%9E%AC%EC%9D%98-%EA%B2%BD%EC%9F%81%EA%B5%AC%EB%8F%84%EC%99%80-%EC%9E%84%EC%83%81-%EC%8B%9C%ED%97%98-%EC%86%8C%EC%8B%9D</loc>
  <lastmod>2023-05-22T17:34:55+09:00</lastmod>
</url>
<url>
  <loc>https://real-world-embedding.tistory.com/m/entry/GLP-1-%EC%88%98%EC%9A%A9%EC%B2%B4-%EC%9E%91%EC%9A%A9%EC%A0%9C-%ED%98%84%EC%9E%AC%EC%9D%98-%EA%B2%BD%EC%9F%81%EA%B5%AC%EB%8F%84%EC%99%80-%EC%9E%84%EC%83%81-%EC%8B%9C%ED%97%98-%EC%86%8C%EC%8B%9D</loc>
  <lastmod>2023-05-22T17:34:55+09:00</lastmod>
</url>
</urlset>